Zoster [herpes zoster]

AB1_ZOSTER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B02 Hospital discharge: ICD-9 — 05[3] Hospital discharge: ICD-8 — 05[3] Cause of death: ICD-10 — B02 Cause of death: ICD-9 — 05[3] Cause of death: ICD-8 — 05[3] 2 out of 7 registries used, show all original rules.	7397
4. Check minimum number of events None	7397
5. Include endpoints None	7397
6. Filter based on genotype QC (FinnGen only)	7397

Control definitions (FinnGen only)

Control exclude: AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_ZOSTER
CONTROL_EXCLUDE	AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B02
HD_ICD_9	05[3]
HD_ICD_8	05[3]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B02
COD_ICD_9	05[3]
COD_ICD_8	05[3]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Zoster [herpes zoster] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	58464	34906	23029
Only index persons	47995	29009	18986
Unadjusted period prevalence (%)
Whole population	0.86	1.00	0.64
Only index persons	0.93	1.07	0.72
Median age at first event (years)
Whole population	68.79	70.21	66.69
Only index persons	67.63	69.09	65.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7397	4353	3044
Unadjusted period prevalence (%)	1.43	1.48	1.34
Median age at first event (years)	66.13	64.57	68.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6522: Matched controls
65220

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H19.2*B02.3

ICD-10 Finland

Keratitis and keratoconjunctivitis (interstitial) in zoster

4470.7

323.0

429

B02.8

ICD-10 Finland

Zoster with other complications

108.4

323.0

435

J05AB11

ATC

valaciclovir; oral

12.6

323.0

2987

4101

B02.9

ICD-10 Finland

Zoster without complication

139.0

323.0

4545

1059

B02

ICD-10 Finland

Zoster [herpes zoster]

9.2

323.0

777

947

J05AB01

ATC

aciclovir; systemic

8.1

323.0

3398

7680

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

1215.5

323.0

453

B02.3

ICD-10 Finland

Zoster ocular disease

525.8

323.0

350

S01AD03

ATC

aciclovir; ophthalmic

14.9

323.0

984

770

G53.0*B02.20

ICD-10 Finland

Trigeminal neuralgia after shingles

+∞

196.8

188

G53.0

ICD-10 Finland

Postzoster neuralgia

27.1

188.0

263

101

N03AX16

ATC

pregabalin; oral

2.4

175.1

1920

9692

S70

ICPC

Herpes zoster

7.0

156.6

408

616

H22.0*B02.3

ICD-10 Finland

Zoster iridocyclitis

+∞

144.3

138

H02AB06

ATC

prednisolone; systemic

1.9

139.6

3261

22180

127

Kela drug reimbursment

Transplant complication

12.1

137.3

258

221

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

687.5

137.2

135

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

134.6

3094

20814

N03AX12

ATC

gabapentin; oral

2.5

134.2

1251

5681

N02AX02

ATC

tramadol; systemic, rectal

1.9

128.6

2947

19684

0539X

ICD-9 Finland

Herpes zoster without mention of complication

+∞

120.2

115

L04AA06

ATC

mycophenolic acid; systemic

9.5

117.3

250

273

B02.0

ICD-10 Finland

Zoster encephalitis

573.0

114.3

113

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.1

113.7

480

1247

R50.9

ICD-10 Finland

Fever, unspecified

2.4

111.4

1089

5019

L04AX01

ATC

azathioprine; systemic

4.2

103.9

425

1071

G53.0*B02.21

ICD-10 Finland

Postherpetic geniculate ganglionitis

177.8

100.6

105

J01DB01

ATC

cefalexin; oral

1.9

94.7

5150

43573

L04AD01

ATC

ciclosporin; systemic

7.2

94.4

239

344

A02BC02

ATC

pantoprazole; systemic

1.7

90.4

4139

32871

N02BE01

ATC

paracetamol; systemic, rectal

1.9

87.2

5508

48087

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

85.1

2342

15925

H13.1*B02.3

ICD-10 Finland

Zoster conjunctivitis

829.0

83.7

A46

ICD-10 Finland

Erysipelas

2.1

82.6

1044

5361

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.0

82.4

526

1874

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

82.1

863

4072

XW000

NOMESCO Finland

Bone marrow biopsy

3.6

81.0

393

1144

B00.10

ICD-10 Finland

Herpes simplex facialis

18.2

79.4

125

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

202.4

77.4

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.8

77.3

532

1987

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

74.2

2722

19854

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

72.6

933

4802

L04AA01

ATC

[U] ciclosporin; systemic

6.7

70.7

187

287

B00.5

ICD-10 Finland

Herpesviral ocular disease

149.7

70.1

N02AA05

ATC

oxycodone; systemic

2.0

69.9

1089

6046

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

68.2

1634

10493

ZX120

NOMESCO Finland

Intravenous

2.3

68.0

697

3230

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

67.2

1899

12791

L03AA02

ATC

filgrastim; parenteral

4.1

66.9

272

679

05306

ICD-8 Finland

Herpes zoster, Alius

+∞

66.8

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

65.0

787

3935

H02AB04

ATC

methylprednisolone; systemic

1.9

64.8

1018

5654

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

64.3

1368

8439

B02.20

ICD-10 Finland

Herpes zoster trigeminal neuralgia

81.0

64.1

H62.1*B02.8

ICD-10 Finland

Otitis externa in zoster

320.2

63.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

63.0

1082

6202

C03CA01

ATC

furosemide; systemic

1.6

62.4

2084

14631

R51.80

ICD-10 Finland

Headache

2.0

62.3

910

4910

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

62.1

2152

15249

H19.2

ICD-10 Finland

Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere

112.8

61.9

Z94.0

ICD-10 Finland

Kidney transplant status

8.9

61.0

133

152

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

60.5

454

1777

J01MA12

ATC

levofloxacin; systemic

1.8

56.3

1215

7487

R06.0

ICD-10 Finland

Dyspnoea

1.7

56.2

1621

10875

WW200

NOMESCO Finland

Immunization

4.0

55.9

238

619

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

55.6

1373

8811

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

54.7

287

886

G530, B028

ICD-10 Finland

+∞

54.2

H02AB09

ATC

hydrocortisone; systemic

4.2

52.5

206

497

G63.0*B02.29

ICD-10 Finland

Postherpetic polyneuropathy

268.0

52.2

J01FF01

ATC

clindamycin; systemic

1.6

51.9

1621

11067

05300

ICD-8 Finland

Herpes zoster, Opthalmicus

+∞

51.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

50.7

2326

17414

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

50.6

2117

15518

B02.7

ICD-10 Finland

Disseminated zoster

257.4

50.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

49.5

2230

16602

M04AA01

ATC

allopurinol; systemic

1.8

48.4

886

5149

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

48.1

1040

6377

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

47.7

330

1230

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.1

47.4

594

2994

B07.9

ICD-10 Finland

Verruca simplex

4.2

46.9

185

449

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

46.7

641

3351

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

46.0

1682

11881

AA1AD

NOMESCO Finland

CT of head and brain

1.6

45.8

1510

10399

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

45.5

2659

20820

H02AB07

ATC

prednisone; oral

1.8

45.3

939

5674

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

44.9

1294

8597

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

30.3

44.8

M79.6

ICD-10 Finland

Pain in limb

1.5

44.8

2093

15618

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

8.8

44.4

112

J01MA02

ATC

ciprofloxacin; systemic

1.5

44.2

2379

18284

UJF32

NOMESCO Finland

Coloscopy

1.6

44.0

1610

11353

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

43.5

654

3536

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

13.2

43.5

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

15.7

42.5

WW500

NOMESCO Finland

Blood transfusion

2.7

42.5

300

1132

SPAT1263

SPAT

Sampling

1.5

42.3

2561

20098

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.1

42.1

J01AA02

ATC

doxycycline; systemic

1.5

41.7

4685

41388

B02.29

ICD-10 Finland

Herpes zoster polyneuropathy

+∞

41.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

41.3

2521

19788

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

41.3

1111

7226

E0000UV

ATC

1.5

41.2

2287

17615

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

40.2

950

5953

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.7

40.1

295

1137

M54.5

ICD-10 Finland

Low back pain

1.5

39.8

1826

13493

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

39.8

977

6190

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

39.5

893

5522

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

39.4

1149

7625

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

39.3

465

2282

R42

ICD-10 Finland

Dizziness and giddiness

1.6

38.8

1378

9601

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

38.6

1565

11239

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

38.5

1034

6708

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

38.4

184

531

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

38.1

1061

6949

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

37.6

870

5413

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

37.4

2182

16881

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

37.4

183

537

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

37.1

402

1895

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

37.0

682

3949

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

37.0

423

2044

J01MA14

ATC

moxifloxacin; systemic

1.9

37.0

553

2976

R03AC02

ATC

salbutamol; inhalant

1.4

36.7

2966

24349

TGC00

NOMESCO Finland

Bronchial lavation

3.2

36.5

203

655

B02.21

ICD-10 Finland

Herpes zoster neuralgia in another cranial nerve

38.6

36.5

A02BC01

ATC

omeprazole; systemic

1.5

36.4

1705

12604

A02BC05

ATC

esomeprazole; systemic

1.4

36.3

2359

18604

WX110

NOMESCO Finland

Local anesthesy

1.4

36.0

3849

33145

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

35.9

333

1458

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.9

35.9

106

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

35.7

600

3367

JN4BD

NOMESCO Finland

Extensive body CT

1.8

35.7

702

4151

P01BA02

ATC

hydroxychloroquine; oral

2.0

35.6

513

2724

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

5.1

35.5

115

229

S18

ICPC

Laceration/cut

1.4

35.5

2456

19563

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

35.3

1017

6707

ZX108

NOMESCO Finland

Inhalation

7.4

35.2

116

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

34.8

218

763

TK800

NOMESCO Finland

Hemodialysis

3.5

34.6

165

475

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

34.6

373

1756

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

34.5

1231

8553

A07AA02

ATC

nystatin; oral

2.0

34.2

438

2218

A04AA01

ATC

ondansetron; systemic, rectal

2.1

34.0

422

2111

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

33.7

424

2130

R4110

NOMESCO Finland

Physiotherapy

1.5

33.7

1543

11316

TAB00

NOMESCO Finland

Lumbar puncture

2.5

33.4

268

1085

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

33.1

1017

6806

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

12.7

32.9

137

Kela drug reimbursment

Uraemia requiring dialysis

6.4

32.9

139

D06BB03

ATC

aciclovir; topical

2.3

32.9

318

1422

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

13.4

32.6

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

32.4

1842

14085

B01.9

ICD-10 Finland

Varicella without complication

27.7

32.3

H22.0*B00.5

ICD-10 Finland

Herpesviral iridocyclitis

+∞

32.3

M05BA04

ATC

alendronic acid; oral

1.8

32.1

587

3385

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

32.1

656

3920

A11CC03

ATC

alfacalcidol; systemic

3.2

32.0

174

554

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

31.9

548

3094

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

31.9

219

813

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

31.7

2764

22774

R53

ICD-10 Finland

Malaise and fatigue

1.5

31.6

1228

8675

C07AB07

ATC

bisoprolol; oral

1.4

31.5

2901

24111

N06AA09

ATC

amitriptyline; systemic

1.8

31.5

627

3713

R06AE07

ATC

cetirizine; oral

1.4

31.5

2396

19286

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.4

30.8

129

05309

ICD-8 Finland

Herpes zoster, Unspecified

+∞

30.2

0538X

ICD-9 Finland

Herpes zoster, With unspecified complication[HERPES ZOSTER ALIUS DEFINITUS]

+∞

30.2

G05.1*B02.0

ICD-10 Finland

Zoster encephalitis

+∞

30.2

WW300

NOMESCO Finland

Transfer of autologic stem cells

10.1

30.0

WW409

NOMESCO Finland

Other aferesis

18.5

30.0

SPAT1301

SPAT

No procedures

1.4

30.0

1896

14743

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

14.8

29.9

J01CA04

ATC

amoxicillin; systemic

1.4

29.6

4660

42036

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

29.6

506

2852

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

9.8

29.5

L03AA13

ATC

pegfilgrastim; parenteral

2.4

29.2

257

1094

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

29.2

254

1076

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

29.1

461

2530

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

29.0

678

4208

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

29.0

1680

12839

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

29.0

805

5238

R60.0

ICD-10 Finland

Localized oedema

1.7

28.9

685

4268

L28

ICPC

Limited function/disability (L)

1.5

28.7

991

6803

R11

ICD-10 Finland

Nausea and vomiting

1.8

28.3

488

2753

B03XA01

ATC

erythropoietin; parenteral

5.3

28.2

165

JN4AD

NOMESCO Finland

Body CT examination

1.9

28.2

457

2524

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

28.2

1791

13904

B05DA

ATC

Isotonic solutions

7.2

28.2

B02.1

ICD-10 Finland

Zoster meningitis

+∞

28.1

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

28.1

1466

10970

SPAT1153

SPAT

Removal of sutures

1.4

27.8

1853

14496

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

27.6

433

2366

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

27.6

476

2690

D07AA02

ATC

hydrocortisone; topical

1.6

27.5

747

4830

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

27.3

1018

7102

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

38.0

27.0

L01BB05

ATC

fludarabine; systemic

23.9

26.9

R52.9

ICD-10 Finland

Pain, unspecified

1.8

26.8

479

2737

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

26.6

533

3161

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

26.4

1073

7620

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

26.2

337

1706

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

26.2

596

3670

J01FA06

ATC

roxithromycin; oral

1.3

26.1

2276

18565

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

26.1

872

5926

Z71.8

ICD-10 Finland

Other specified counselling

1.4

26.1

1247

9156

G02.0*B02.1

ICD-10 Finland

Zoster meningitis

+∞

26.1

G51.0

ICD-10 Finland

Bell palsy

2.8

25.9

174

637

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

25.7

647

4092

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.3

25.7

240

1056

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

25.7

854

5797

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

25.6

341

1752

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

25.6

1543

11831

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

25.5

530

3175

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

25.4

850

5779

B01AB05

ATC

enoxaparin; parenteral

1.4

25.3

1750

13731

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

25.3

451

2571

H57.1

ICD-10 Finland

Ocular pain

2.6

25.3

184

709

N06AX21

ATC

duloxetine; oral

1.7

25.2

567

3475

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

25.2

316

1586

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

25.0

2227

18189

P01AB01

ATC

metronidazole; oral, rectal

1.3

25.0

2129

17272

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.7

24.9

112

309

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.9

24.8

120

N05CF01

ATC

zopiclone; oral

1.4

24.8

1893

15089

J02AC01

ATC

fluconazole; systemic

1.3

24.7

2072

16763

C90.0

ICD-10 Finland

Multiple myeloma

4.1

24.7

238

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

24.6

187

739

J01DA01

ATC

[U] cefalexin; systemic

1.3

24.6

3606

31655

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

24.5

136

441

SPAT1262

SPAT

Handing over of treatment supplies

1.5

24.5

1030

7360

D07AC01

ATC

betamethasone; topical

1.4

24.4

1870

14903

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.4

24.2

120

358

WX002

NOMESCO Finland

Sedation and analgesia

1.4

24.1

1143

8366

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

24.0

249

SPAT1312

SPAT

General health counselling

1.4

23.7

1769

14024

S29

ICPC

Skin symptom/complaint other

1.5

23.6

938

6614

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

23.6

260

1236

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

23.4

891

6227

ZXA00

NOMESCO Finland

Right side

1.4

23.3

1577

12300

H02AB02

ATC

dexamethasone; systemic

1.6

23.0

582

3681

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

22.8

169

660

SPAT1254

SPAT

Administration of medicine

1.5

22.7

893

6284

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.4

22.5

192

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

22.5

430

2508

SPAT1325

SPAT

Vaccination

1.3

22.5

2049

16725

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

22.5

258

1249

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.8

22.4

151

557

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.7

22.4

156

588

A12AA04

ATC

calcium carbonate; oral

3.3

22.3

112

339

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

22.2

579

3694

M03BX02

ATC

tizanidine; oral

1.3

22.2

3238

28215

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

22.2

526

3270

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

22.1

165

647

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

22.0

301

1563

S01

ICPC

Pain/tenderness of skin

2.1

22.0

254

1231

H26.3

ICD-10 Finland

Drug-induced cataract

7.2

21.9

H16.0

ICD-10 Finland

Corneal ulcer

2.1

21.6

243

1166

Z49.2

ICD-10 Finland

Other dialysis

6.2

21.6

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.5

21.6

173

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

21.5

1925

15646

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

21.5

171

695

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

5.1

21.4

135

N03AF01

ATC

carbamazepine; oral, rectal

1.9

21.3

312

1664

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.6

21.2

160

631

B05DB

ATC

Hypertonic solutions

6.5

21.2

C08CA01

ATC

amlodipine; oral

1.3

21.2

2079

17121

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

21.1

438

2619

A01

ICPC

Pain general/multiple sites

1.7

21.1

443

2659

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

21.0

224

1051

B01AA03

ATC

warfarin; systemic

1.4

20.9

1241

9434

B02.2

ICD-10 Finland

Zoster with other nervous system involvement

60.2

20.9

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

+∞

20.8

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.0

20.8

291

1522

R07.3

ICD-10 Finland

Other chest pain

1.6

20.6

517

3263

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.4

20.6

172

ZXA10

NOMESCO Finland

Bilateral

1.4

20.6

1084

8065

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

20.6

287

1501

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

20.6

419

2493

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

20.6

672

4533

SPAT1310

SPAT

Counselling related to known health issue

1.3

20.6

1748

14083

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

20.5

434

2609

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

20.5

139

515

A06AD11

ATC

lactulose; oral

1.5

20.5

886

6350

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

20.5

662

4454

A02BC03

ATC

lansoprazole; oral

1.3

20.2

1651

13214

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

20.2

270

1392

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.4

20.2

295

V03AE02

ATC

sevelamer; oral

7.3

20.1

H01.0

ICD-10 Finland

Blepharitis

2.0

20.1

275

1428

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

20.1

1079

8057

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

20.0

1911

15642

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

20.0

352

1998

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

17.3

20.0

N30.0

ICD-10 Finland

Acute cystitis

1.5

19.9

808

5715

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

19.8

449

2753

J01FA10

ATC

azithromycin; systemic

1.3

19.7

3006

26175

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

19.7

395

2340

V03AE01

ATC

polystyrene sulfonate; oral

3.5

19.6

265

SPAT1260

SPAT

Consultation of another employee

1.4

19.6

996

7359

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

19.4

551

3589

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

19.4

940

6879

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

19.3

583

3855

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

19.3

109

360

S97

ICPC

Chronic ulcer skin

1.8

19.2

316

1757

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

15.6

19.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

19.2

213

1017

Z00.0

ICD-10 Finland

General medical examination

1.4

19.2

984

7281

SPAT1255

SPAT

Intravenous administration of medicine

1.7

19.1

371

2173

D07AC13

ATC

mometasone; topical

1.3

19.1

1520

12097

6BA02

NOMESCO Finland

9.3

19.0

R55

ICD-10 Finland

Syncope and collapse

1.5

19.0

628

4244

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

19.0

223

1091

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

18.9

1389

10912

H22.0

ICD-10 Finland

Iridocyclitis in infectious and parasitic diseases classified elsewhere

55.2

18.9

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.6

18.9

237

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

34.4

18.9

H16.9

ICD-10 Finland

Keratitis, unspecified

3.2

18.8

306

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

18.8

643

4376

G44.2

ICD-10 Finland

Tension-type headache

1.5

18.8

660

4522

ZXA05

NOMESCO Finland

Left side

1.3

18.7

1457

11555

L17

ICPC

Foot/toe symptom/complaint

1.3

18.7

1347

10553

N18.0

ICD-10 Finland

End-stage renal disease

3.5

18.6

256

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

9.3

18.5

ZX112

NOMESCO Finland

Subcutaneous

2.6

18.5

139

548

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

18.5

224

1108

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

18.5

258

1352

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

18.5

508

3283

K02.1

ICD-10 Finland

Caries of dentine

1.3

18.4

2841

24699

M25.5

ICD-10 Finland

Pain in joint

1.3

18.4

1414

11183

A02BA02

ATC

ranitidine; systemic

1.4

18.3

1139

8708

L57.0

ICD-10 Finland

Actinic keratosis

1.5

18.3

574

3834

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

4.8

18.2

129

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

18.2

102

336

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

18.1

607

4112

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

18.1

394

2392

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

9.8

18.1

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

18.1

129

495

L01AA01

ATC

cyclophosphamide; systemic

5.8

18.0

SPAT1211

SPAT

Application of soft bandage

1.6

17.9

505

3284

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

17.9

877

6427

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

13.0

17.9

1XC02

NOMESCO Finland

4.3

17.8

151

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.4

17.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

17.7

1216

9442

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

17.7

1198

9284

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.5

17.6

134

533

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

17.6

406

2502

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

13.1

17.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

17.4

887

6548

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.5

17.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

17.3

123

470

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

17.2

177

818

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

17.2

1734

14242

M79.1

ICD-10 Finland

Myalgia

1.5

17.2

642

4452

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

17.2

1420

11337

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

17.2

287

1606

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

17.1

779

5624

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.8

17.1

110

396

D07AB08

ATC

desonide; topical

1.5

17.1

547

3668

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

6.7

17.0

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

8.0

17.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

16.9

404

2517

H01

ICPC

Ear pain/earache

1.6

16.9

499

3280

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

16.9

328

1923

L01BB02

ATC

mercaptopurine; oral

4.4

16.9

140

L04AA13

ATC

leflunomide; oral

2.4

16.9

147

626

A07EA06

ATC

budesonide; oral, local oral

2.1

16.8

182

862

J02AC03

ATC

voriconazole; systemic

12.0

16.8

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

16.8

384

2362

Z85.6

ICD-10 Finland

Personal history of leukaemia

63.5

16.7

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

16.7

340

2022

0532A

ICD-9 Finland

Herpes zoster, With ophthalmic complications[HERPES ZOSTER PALPEBRAE OCULI]

+∞

16.7

L01BB01

ATC

8.8

16.6

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

9.7

16.6

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

9.7

16.6

A05AA02

ATC

ursodeoxycholic acid; oral

2.9

16.5

342

N05BA04

ATC

oxazepam; oral

1.3

16.5

1323

10506

A98

ICPC

Health maint/preventive medicine

1.4

16.5

5763

55139

WZC30

NOMESCO Finland

Teaching

1.5

16.4

679

4810

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

5.1

16.4

100

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

8.2

16.4

R05

ICD-10 Finland

Cough

1.4

16.4

998

7590

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

16.4

364

2220

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

16.3

204

G47.3

ICD-10 Finland

Sleep apnoea

1.4

16.3

973

7375

C10AA05

ATC

atorvastatin; oral

1.3

16.3

2124

18005

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

16.2

956

7227

R03BB04

ATC

tiotropium bromide; inhalant

1.5

16.1

559

3817

L04AX04

ATC

lenalidomide; oral

5.5

16.1

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

16.1

123

491

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.2

16.0

265

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

16.0

207

R52.2

ICD-10 Finland

Other chronic pain

2.1

16.0

185

901

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

16.0

286

1636

M05BX04

ATC

denosumab; parenteral

1.8

16.0

300

1741

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

16.0

321

1902

L12

ICPC

Hand/finger symptom/complaint

1.4

15.9

693

4956

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

15.9

209

1071

L20.0

ICD-10 Finland

Besnier prurigo

1.8

15.9

265

1480

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

15.9

1364

10932

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

15.9

2799

24562

R01AD09

ATC

mometasone; nasal

1.3

15.8

2223

18994

UKC02

NOMESCO Finland

Cystoscopy

1.4

15.8

884

6624

R04.0

ICD-10 Finland

Epistaxis

1.6

15.7

400

2534

E000001

ATC

1.4

15.7

1061

8202

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.2

15.6

156

713

G530, B029

ICD-10 Finland

+∞

15.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

15.6

227

1209

M48.0

ICD-10 Finland

Spinal stenosis

1.4

15.6

684

4899

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

15.6

275

1567

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

15.6

208

1073

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

15.6

377

2357

SPAT1216

SPAT

Assessment of functional ability

1.4

15.5

893

6723

5AB14

NOMESCO Finland

13.7

15.5

Z94.2

ICD-10 Finland

Lung transplant status

13.7

15.5

L04AB04

ATC

adalimumab; parenteral

2.9

15.4

334

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

15.4

178

867

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

15.4

783

5768

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

15.4

982

7523

ZX121

NOMESCO Finland

Central venous catheter

6.5

15.3

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

15.3

310

1844

R02

ICPC

Shortness of breath/dyspnoea

1.5

15.3

646

4594

A07EC02

ATC

mesalazine; oral, rectal

1.8

15.3

265

1503

L03

ICPC

Low back symptom/complaint

1.3

15.2

1219

9668

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

15.1

117

470

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

15.1

633

4494

153

Kela drug reimbursment

Lenalidomid

5.0

15.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

15.1

2668

23369

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

15.0

257

1451

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

9.4

14.9

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

14.9

192

977

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

14.9

172

838

J01FA09

ATC

clarithromycin; systemic

1.3

14.9

1543

12677

ZXC50

NOMESCO Finland

Cryotherapy

2.0

14.9

181

901

J05AB09

ATC

famciclovir; oral

4.9

14.9

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

7.6

14.8

5BA08

NOMESCO Finland

4.7

14.8

108

XQ848

NOMESCO Finland

Dermatological photography

2.2

14.8

148

679

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

14.8

399

2565

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

14.8

513

3502

WX892

NOMESCO Finland

Monitored bed care

1.6

14.8

396

2543

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

14.8

230

1256

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

14.7

1266

10138

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.0

14.7

280

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

14.7

350

2178

Z94.4

ICD-10 Finland

Liver transplant status

7.4

14.6

C03DA01

ATC

spironolactone; oral

1.5

14.6

604

4273

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

14.6

679

4916

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

14.6

1341

10836

E000006

ATC

1.6

14.6

375

2381

Z01.2

ICD-10 Finland

Dental examination

1.3

14.6

1980

16810

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

14.6

1365

11058

J01CF05

ATC

flucloxacillin; systemic

2.0

14.5

196

1019

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

14.4

960

7397

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

14.4

481

3252

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

14.4

223

1218

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

14.3

3641

33088

G04CA02

ATC

tamsulosin; oral

1.3

14.3

1150

9114

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

4.5

14.3

112

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.0

14.3

266

7151

FHL

Kidney transplantation

17.0

14.3

X58

ICD-10 Finland

Exposure to other specified factors

1.4

14.3

623

4459

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

14.2

518

3573

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

14.2

253

1447

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.4

14.1

197

R05

ICPC

Cough

1.3

14.1

1115

8820

A28

ICPC

Limited function/disability NOS

1.4

14.0

868

6604

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

14.4

14.0

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

14.0

1548

12809

K50.8

ICD-10 Finland

Other Crohn disease

3.0

14.0

268

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.0

13.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.9

303

1842

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

13.9

100

389

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.5

13.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

13.8

793

5958

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

13.8

351

2223

S76

ICPC

Skin infection other

1.7

13.8

264

1545

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

13.8

1515

12520

B00.11

ICD-10 Finland

Herpes simplex labialis

3.5

13.7

181

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.1

13.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

13.7

437

2924

Z94.1

ICD-10 Finland

Heart transplant status

8.6

13.7

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

10.4

13.7

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

13.6

474

3238

0532X

ICD-9 Finland

Herpes zoster, With ophthalmic complications[HERPES ZOSTER CUM COMPLICATIONE OPHTALMICA ALIA]

+∞

13.5

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

13.5

134

613

S21

ICPC

Skin texture symptom/complaint

1.4

13.5

624

4512

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

13.5

2375

20713

A04AA02

ATC

granisetron; systemic, transdermal

1.6

13.5

314

1944

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

13.4

342

2172

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

25.8

13.3

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.2

13.3

139

649

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.1

13.3

149

719

N06AB04

ATC

citalopram; systemic

1.3

13.3

1092

8672

N19

ICD-10 Finland

Unspecified kidney failure

1.9

13.3

188

994

RS220

NOMESCO Finland

3.0

13.3

255

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

13.8

13.2

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.8

13.2

298

L03.2

ICD-10 Finland

Cellulitis of face

4.6

13.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

13.2

667

4902

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

13.1

205

1123

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

13.1

3391

30736

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

13.1

126

569

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

13.0

3239

29239

R4190

NOMESCO Finland

Nutritional therapy

2.1

12.9

153

755

SPAT1229

SPAT

Assessment of need for aid

1.5

12.9

454

3105

XF404

NOMESCO Finland

Ambulatory ECG

1.5

12.9

494

3443

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

6.1

12.8

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

12.8

305

1901

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

12.7

161

817

R13

ICD-10 Finland

Dysphagia

1.6

12.7

330

2102

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

12.7

360

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.2

12.7

127

584

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.8

12.6

137

N01

ICPC

Headache

1.5

12.6

444

3041

A07AA09

ATC

vancomycin; oral

2.7

12.5

314

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

7.0

12.5

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.1

12.5

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

12.5

245

1442

H62.1*B00.19

ICD-10 Finland

Otitis externa in herpesviral [herpes simplex] infection

+∞

12.5

0531A

ICD-9 Finland

Herpes zoster, With other nervous system complications

+∞

12.5

H191, B023

ICD-10 Finland

+∞

12.5

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

+∞

12.5

C01DA14

ATC

isosorbide mononitrate; oral

1.3

12.5

937

7340

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

12.5

318

2014

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

8.7

12.5

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.9

12.4

173

909

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

12.4

461

3191

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

12.4

2792

24906

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.0

12.4

238

R52.0

ICD-10 Finland

Acute pain

2.0

12.4

149

740

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

12.4

1175

9512

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

12.3

139

672

390

Kela drug reimbursment

Ibrutinib

11.6

12.3

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

12.3

654

4851

GDG10

NOMESCO Finland

Bilateral transplantation of lung

14.3

12.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

12.2

241

1425

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

12.2

312

1981

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

12.2

259

1564

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

12.2

528

3774

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.1

12.1

211

M01AE02

ATC

naproxen; oral, rectal

1.2

12.0

2961

26615

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.2

12.0

117

532

S19

ICPC

Skin injury other

1.8

11.9

196

1092

M01CB01

ATC

sodium aurothiomalate; parenteral

2.5

11.9

377

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

11.9

480

3381

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

11.9

234

1384

S06.0

ICD-10 Finland

Concussion

1.4

11.8

499

3546

A01AB09

ATC

miconazole; local oral

1.5

11.8

475

3340

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

11.8

514

3673

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

11.8

1012

8072

M10.9

ICD-10 Finland

Gout, unspecified

1.6

11.8

322

2078

B01AB10

ATC

tinzaparin; parenteral

1.6

11.8

348

2287

5AB01

NOMESCO Finland

11.7

11.8

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

11.8

233

1379

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.2

11.7

329

Kela drug reimbursment

Lenalidomide

5.6

11.7

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

11.7

142

710

R03BA08

ATC

ciclesonide; inhalant

1.5

11.7

381

2563

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

11.7

1050

8430

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.4

11.7

168

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.4

11.7

403

XQ800

NOMESCO Finland

Prick test

1.6

11.7

325

2110

R06AX27

ATC

desloratadine; oral

1.3

11.6

1206

9862

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

11.6

214

1239

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

7.7

11.6

XCH00

NOMESCO Finland

Eye pressure measurement

1.8

11.5

213

1233

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

11.5

430

2979

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

11.5

2006

17399

J20

ICD-10 Finland

Acute bronchitis

1.5

11.5

451

3156

N06AX11

ATC

mirtazapine; oral

1.2

11.5

1619

13728

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

11.5

1162

9470

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.7

11.5

281

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

11.5

326

2123

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.2

11.5

181

05307

ICD-8 Finland

Herpes zoster, Suspectus

+∞

11.5

H19.0*B02.3

ICD-10 Finland

Zoster scleritis

+∞

11.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

11.5

335

2200

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.7

11.5

225

1330

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.0

11.4

225

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

11.4

118

550

V03AE03

ATC

lanthanum carbonate; oral

7.5

11.4

A41.8

ICD-10 Finland

Other specified sepsis

2.3

11.4

100

434

A10AE05

ATC

insulin detemir; parenteral

1.6

11.4

263

1626

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

11.4

441

3083

XCK00

NOMESCO Finland

Perimetry

1.5

11.4

352

2342

WZA90

NOMESCO Finland

Other doctors statement

1.3

11.3

1089

8820

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

11.3

1209

9925

1512

Kela drug reimbursment

Ibrutinib

11.8

11.3

H13.1

ICD-10 Finland

Conjunctivitis in infectious and parasitic diseases classified elsewhere

15.0

11.3

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.5

11.3

351

2337

K51.5

ICD-10 Finland

Left sided colitis

2.1

11.2

118

557

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

8.9

11.2

TPX15

NOMESCO Finland

Removal of vascular injection port

4.5

11.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

11.2

722

5523

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

11.2

165

888

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

11.2

330

2171

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

11.1

237

1433

2AX04

NOMESCO Finland

20.0

11.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

11.1

300

1933

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

11.1

454

3209

A04

ICPC

Weakness/tiredness general

1.4

11.1

679

5154

Z51.5

ICD-10 Finland

Palliative care

1.6

11.1

320

2098

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

11.1

466

3308

C83.00

ICD-10 Finland

Lymphocytic lymphoma

6.4

11.0

R31

ICD-10 Finland

Unspecified haematuria

1.4

11.0

507

3661

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

11.0

364

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

11.0

128

632

1CX01

NOMESCO Finland

10.0

11.0

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

11.0

498

3588

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

13.9

10.9

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

10.9

268

1685

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

10.9

149

782

K07.60

ICD-10 Finland

Snapping jaw

1.7

10.9

202

1172

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

10.9

216

1279

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

10.9

475

3395

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

10.9

475

3397

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

10.9

787

6128

I50.0

ICD-10 Finland

Congestive heart failure

1.5

10.8

418

2919

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

10.8

586

4362

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.3

10.7

433

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

10.7

293

1892

WX402

NOMESCO Finland

General anaesthesia

1.3

10.7

742

5735

B00.0

ICD-10 Finland

Eczema herpeticum

5.0

10.7

N03AE01

ATC

clonazepam; systemic

1.6

10.7

287

1847

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

10.7

103

465

187

Kela drug reimbursment

MPA

28.0

10.7

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

17.8

10.7

RS221

NOMESCO Finland

2.5

10.7

339

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.7

837

6592

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

10.7

272

1727

N06AX16

ATC

venlafaxine; oral

1.4

10.7

586

4369

B01AC04

ATC

clopidogrel; oral

1.3

10.7

839

6611

C82.1

ICD-10 Finland

Follicular lymphoma grade II

3.6

10.6

133

W19

ICD-10 Finland

Unspecified fall

1.4

10.6

470

3373

AN1

Coronary angiography

1.4

10.6

633

4782

H02.4

ICD-10 Finland

Ptosis of eyelid

1.9

10.6

142

740

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

10.6

1234

10227

207

Kela drug reimbursment

Chronic arrhythmias

1.3

10.5

800

6272

H25.8

ICD-10 Finland

Other senile cataract

1.4

10.5

624

4707

R4180

NOMESCO Finland

Podiatric therapy

3.0

10.5

188

S71

ICPC

Herpes simplex

3.8

10.5

114

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.3

10.5

423

M32

ICD-10 Finland

Systemic lupus erythematosus

14.2

10.5

D11AX14

ATC

[U] tacrolimus; topical

5.2

10.4

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

10.4

403

2819

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.9

10.4

138

716

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

10.4

374

2577

JJC00

NOMESCO Finland

Allogenic transplantation of liver

7.7

10.4

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

10.3

158

864

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.6

10.3

290

A29

ICPC

General symptom/complaint other

1.4

10.3

562

4183

ZX114

NOMESCO Finland

Intramuscular

2.4

10.3

334

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.3

605

4561

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.4

10.3

137

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

10.3

157

856

H26.4

ICD-10 Finland

After-cataract

1.4

10.3

523

3850

N03AX09

ATC

lamotrigine; oral

1.8

10.2

178

1014

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

18.8

10.2

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.8

10.2

229

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.0

10.2

201

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

10.2

272

1745

R51.81

ICD-10 Finland

Facial pain NOS

2.2

10.2

103

478

J01EA01

ATC

trimethoprim; systemic

1.2

10.2

1387

11691

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

10.2

427

3031

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

10.2

685

5275

C07AB02

ATC

metoprolol; systemic

1.3

10.1

1183

9802

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.0

10.1

123

616

J01CA08

ATC

pivmecillinam; oral

1.2

10.1

2125

18718

R33

ICD-10 Finland

Retention of urine

1.5

10.1

394

2758

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

10.1

352

2406

B01AB04

ATC

dalteparin; parenteral

1.6

10.1

250

1577

M05BA07

ATC

risedronic acid; oral

1.7

10.1

198

1170

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

10.1

198

1170

212

Kela drug reimbursment

Gout

2.1

10.1

114

557

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

10.1

417

2954

R03BA05

ATC

fluticasone; inhalant

1.3

10.0

883

7062

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

10.0

698

5400

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

10.0

101

468

C09CA01

ATC

losartan; oral

1.2

10.0

1245

10387

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.8

10.0

218

J01XX08

ATC

linezolid; systemic

4.1

10.0

D09AB01

ATC

zinc bandage without supplements; topical

2.1

10.0

108

516

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

10.0

141

749

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.7

10.0

195

1152

D07AD01

ATC

clobetasol; topical

1.3

9.9

740

5784

M01AC06

ATC

meloxicam; systemic, rectal

1.2

9.9

1884

16430

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

16.7

9.9

SBB10

NOMESCO Finland

Teeth copy

1.6

9.9

254

1621

C83.1

ICD-10 Finland

Mantle cell lymphoma

4.3

9.8

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.7

9.8

247

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

9.8

621

4732

QDA50

NOMESCO Finland

Cryotherapy of skin of lower limb

12.2

9.8

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

12.2

9.8

L04AA05

ATC

[U] tacrolimus; systemic

12.2

9.8

F29

ICPC

Eye symptom/complaint other

1.5

9.8

387

2716

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

5.2

9.8

N03

ICPC

Pain face

3.2

9.8

159

H01AC01

ATC

somatropin; parenteral

8.7

9.8

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

9.8

317

2136

K59.0

ICD-10 Finland

Constipation

1.5

9.7

290

1916

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

9.5

9.7

TK820

NOMESCO Finland

Peritoneal dialysis

4.8

9.7

S06

ICPC

Rash localized

1.6

9.7

271

1762

WVA20

NOMESCO Finland

Medicine administration

2.1

9.7

101

474

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

9.7

283

1862

H05BX01

ATC

cinacalcet; oral

4.0

9.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

9.7

292

1935

M54.2

ICD-10 Finland

Cervicalgia

1.5

9.7

313

2109

SPAT1234

SPAT

Support of social functional capacity

1.5

9.6

278

1823

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

5.8

9.6

E000002

ATC

1.4

9.6

519

3858

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.6

1116

9238

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

9.6

621

4753

CG2S4

NOMESCO Finland

Photography of cornea

4.4

9.6

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

9.6

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

9.6

134

711

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.5

9.6

124

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

9.6

179

1043

A10AE04

ATC

insulin glargine; parenteral

1.4

9.6

442

3196

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

9.5

108

529

N02AC04

ATC

dextropropoxyphene; oral

1.7

9.5

208

1269

J46

ICD-10 Finland

Status asthmaticus

1.9

9.5

139

747

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

9.5

464

3388

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

9.5

177

1034

-1

NOMESCO Finland

1.2

9.5

1541

13221

D02AE01

ATC

carbamide; topical

1.5

9.5

315

2134

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

9.5

216

1337

H92.0

ICD-10 Finland

Otalgia

1.6

9.5

227

1421

G530, B022

ICD-10 Finland

100.2

9.4

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

30.0

9.4

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

30.0

9.4

C08CA13

ATC

lercanidipine; oral

1.3

9.4

673

5227

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

1.7

9.4

179

1050

0530A

ICD-9 Finland

Herpes zoster, With meningitis

+∞

9.4

G05.1*B01.1

ICD-10 Finland

Varicella encephalitis

+∞

9.4

UDC00

NOMESCO Finland

Ear microscopy

1.5

9.4

337

2321

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.7

9.4

177

1036

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.5

9.3

295

N05BB01

ATC

hydroxyzine; systemic

1.5

9.3

309

2090

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

12.3

9.3

L01XE27

ATC

[U] ibrutinib; oral

12.3

9.3

ZX131

NOMESCO Finland

Intrathecal

21.7

9.3

L05

ICPC

Flank/axilla symptom/complaint

1.6

9.3

257

1667

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.3

3619

33557

L50.0

ICD-10 Finland

Allergic urticaria

1.9

9.3

123

639

H13

ICPC

Plugged feeling ear

1.3

9.2

905

7331

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

9.2

930

7560

H53.2

ICD-10 Finland

Diplopia

1.8

9.2

145

802

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

9.2

217

1354

A86

ICD-10 Finland

Unspecified viral encephalitis

4.1

9.2

R03BA01

ATC

beclometasone; inhalant

1.3

9.2

696

5449

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.5

9.2

118

R01AD08

ATC

fluticasone; nasal

1.2

9.2

1316

11142

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.3

9.2

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.7

9.2

234

C08CA05

ATC

nifedipine; systemic

1.5

9.2

346

2408

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

9.1

1020

8396

R03AC12

ATC

salmeterol; inhalant

1.6

9.1

243

1564

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

9.1

124

651

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

3.2

9.1

140

R5120

NOMESCO Finland

Preparation of an aid

1.9

9.1

136

739

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.1

349

2436

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

9.1

1121

9336

C01CA24

ATC

epinephrine; parenteral

1.6

9.1

242

1558

R01AD12

ATC

fluticasone furoate; nasal

1.2

9.0

1275

10773

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

5.9

9.0

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

9.0

510

3821

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

15.6

9.0

B00.8

ICD-10 Finland

Other forms of herpesviral infection

10.0

9.0

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.4

9.0

372

2633

Z50.1

ICD-10 Finland

Other physical therapy

1.5

9.0

269

1782

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

2.8

8.9

199

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.7

8.9

223

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

8.9

245

1589

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

8.9

539

4082

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.9

8.9

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.8

8.9

136

746

F01

ICPC

Eye pain

1.9

8.9

122

645

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

8.9

132

718

L01EL01

ATC

ibrutinib; oral

12.5

8.8

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

8.8

162

942

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.8

766

6111

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.2

8.8

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.2

8.8

396

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

7.9

8.8

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

7.9

8.8

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

8.8

516

3885

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

8.8

141

782

D11AH01

ATC

tacrolimus; topical

3.4

8.8

117

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.6

8.8

228

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

8.8

379

2706

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

8.8

304

2079

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

8.8

283

1902

Z99.2

ICD-10 Finland

Dependence on renal dialysis

10.7

8.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

8.8

409

2966

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.9

8.8

177

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.4

8.7

118

A03

ICPC

Fever

1.3

8.7

649

5067

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.9

8.7

116

604

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3.9

8.7

WF049

NOMESCO Finland

Radiotherapy of metastasis

1.7

8.7

155

895

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.8

8.6

153

882

K30

ICD-10 Finland

Functional dyspepsia

1.4

8.6

475

3544

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.6

1540

13323

G35

ICD-10 Finland

Multiple sclerosis

2.4

8.6

287

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.3

8.6

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.5

8.6

259

JN4CD

NOMESCO Finland

Very extensive body CT

1.6

8.6

200

1244

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.8

8.6

150

858

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

8.6

115

600

R4120

NOMESCO Finland

Occupational therapy

1.5

8.6

285

1932

XQ802

NOMESCO Finland

Epicutan test

1.7

8.6

168

997

A10BH01

ATC

sitagliptin; oral

1.4

8.6

453

3358

HA1AA

NOMESCO Finland

X-ray mammography

1.4

8.5

355

2519

T90

ICPC

Diabetes non-insulin dependent

1.2

8.5

1136

9534

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

8.5

247

1624

D01

ICPC

Abdominal pain/cramps general

1.4

8.5

468

3490

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.2

8.5

361

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.5

8.5

264

G50.1

ICD-10 Finland

Atypical facial pain

2.2

8.5

383

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.5

3501

32501

A12BA01

ATC

potassium chloride; oral

1.5

8.4

270

1814

K08.80

ICD-10 Finland

Toothache NOS

1.5

8.4

308

2132

H62.1

ICD-10 Finland

Otitis externa in viral diseases classified elsewhere

90.2

8.4

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.0

8.4

155

C09AA05

ATC

ramipril; oral

1.2

8.4

1326

11327

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

3.7

8.4

C02AC05

ATC

moxonidine; oral

1.6

8.4

222

1426

C10AA01

ATC

simvastatin; oral

1.2

8.4

2467

22284

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

8.4

333

2344

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.2

8.4

366

B01AF02

ATC

apixaban; oral

1.4

8.4

497

3753

L01AA02

ATC

chlorambucil; oral

4.2

8.4

0532B

ICD-9 Finland

Herpes zoster, With ophthalmic complications[HERPES ZOSTER KERATOCONJUNCTIVITIS]

+∞

8.3

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

8.3

439

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.0

8.3

464

I50.1

ICD-10 Finland

Left ventricular failure

1.5

8.2

238

1565

E000003

ATC

1.6

8.2

203

1281

K51.8

ICD-10 Finland

Other ulcerative colitis

2.4

8.2

264

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

8.2

360

2578

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.4

8.2

349

2487

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

8.2

375

2706

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

8.2

266

1795

H03AA01

ATC

levothyroxine sodium; systemic

1.2

8.2

1190

10078

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

8.2

178

1090

R74

ICPC

Upper respiratory infection acute

1.2

8.2

1177

9959

M01AX17

ATC

nimesulide; oral

1.2

8.2

1289

11006

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.0

8.1

486

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

7.5

8.1

S22.3

ICD-10 Finland

Fracture of rib

1.5

8.1

291

2004

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

8.1

463

3473

R03DC03

ATC

montelukast; oral

1.3

8.1

723

5787

M35.1

ICD-10 Finland

Other overlap syndromes

3.6

8.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

8.1

368

2653

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

8.1

398

2914

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.5

8.1

239

1579

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

8.1

643

5070

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

17.2

8.1

E86

ICD-10 Finland

Volume depletion

1.8

8.1

127

704

ZX197

NOMESCO Finland

11.7

8.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.8

8.1

142

817

H00.03

ICD-10 Finland

Preseptal cellulite in the eyelid

4.4

8.0

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

8.0

334

2372

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

8.9

8.0

J45.8

ICD-10 Finland

Mixed asthma

1.7

8.0

147

856

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.2

8.0

364

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

8.0

178

1096

A10BH05

ATC

linagliptin; oral

1.5

8.0

242

1609

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.4

7.9

264

SPAT1167

SPAT

Insertion of urinary catheter

1.7

7.9

169

1029

L29

ICPC

Musculoskeletal sympt/complt other

1.4

7.9

352

2529

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.3

7.9

295

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.9

7.9

116

628

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

7.9

1520

13223

L13

ICPC

Hip symptom/complaint

1.3

7.9

778

6304

R21

ICPC

Throat symptom/complaint

1.3

7.9

809

6588

J02AC04

ATC

posaconazole; systemic

13.0

7.9

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.4

7.9

259

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.0

7.8

101

521

D11AH02

ATC

pimecrolimus; topical

5.1

7.8

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

7.8

168

1026

R04.2

ICD-10 Finland

Haemoptysis

1.7

7.8

171

1047

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

7.8

134

763

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

7.8

862

7083

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

7.8

457

3442

K03.66

ICD-10 Finland

Tooth plaque

1.5

7.8

287

1987

B72

ICPC

Hodgkin Lymphoma

8.4

7.8

I20.09

ICD-10 Finland

Unstable angina

1.5

7.8

290

2016

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

7.8

255

1725

ZZA00

NOMESCO Finland

Split skin graft

1.7

7.8

143

833

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

7.8

138

798

C10AA03

ATC

pravastatin; oral

1.4

7.7

366

2661

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.5

7.7

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.1

7.7

392

7101

FHL

Needle biopsy in the operating room

45.0

7.7

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

7.7

491

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.9

7.7

102

532

A07EA02

ATC

hydrocortisone; rectal

1.9

7.7

104

547

RD210

NOMESCO Finland

2.1

7.7

381

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

7.7

219

1435

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

7.7

180

M31.3

ICD-10 Finland

Wegener granulomatosis

4.2

7.7

M54.3

ICD-10 Finland

Sciatica

1.5

7.7

261

1780

SPAT1097

SPAT

Recording of ECG

1.3

7.7

770

6252

S01BC05

ATC

ketorolac; ophthalmic

1.6

7.7

213

1390

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.2

7.6

115

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

7.6

189

1199

L08

ICPC

Shoulder symptom/complaint

1.2

7.6

877

7239

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.3

7.6

105

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

7.6

736

5955

2041A

ICD-9 Finland

Lymphoid leukaemia, Chronic

25.0

7.6

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.6

5028

48236

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.9

7.5

154

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

7.5

320

2283

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

1.9

7.5

519

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

1.7

7.5

135

783

R83

ICPC

Respiratory infection other

1.2

7.5

908

7536

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.4

7.5

101

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.5

7.5

210

K07

ICPC

Swollen ankles/oedema

1.5

7.5

224

1486

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

7.4

233

1563

R03BA02

ATC

budesonide; inhalant

1.2

7.4

833

6855

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

7.4

446

3375

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.6

7.4

5BA03

NOMESCO Finland

80.2

7.4

M05BA01

ATC

etidronic acid; systemic

2.9

7.4

150

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

1.8

7.4

118

660

L14

ICPC

Leg/thigh symptom/complaint

1.4

7.4

338

2444

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.3

7.4

488

3745

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.4

2065

18528

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

7.4

498

3837

M01AH02

ATC

rofecoxib; oral

1.3

7.4

680

5464

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

13.4

7.4

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

7.6

7.4

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.1

7.4

124

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

7.4

437

SPAT1053

SPAT

Memory test

1.2

7.3

830

6833

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

7.3

251

1714

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.2

7.3

333

SPAT1131

SPAT

Colonoscopy

1.6

7.3

161

988

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.6

7.3

201

1305

C09CA06

ATC

candesartan; oral

1.2

7.3

1034

8724

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

2.1

7.3

368

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.4

7.3

251

BE00A

NOMESCO Finland

+∞

7.3

G02.0*B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

7.3

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

+∞

7.3

G02.0*B01.0

ICD-10 Finland

Varicella meningitis

+∞

7.3

G530, B0229

ICD-10 Finland

+∞

7.3

305

Kela drug reimbursment

MPA

+∞

7.3

ZX100

NOMESCO Finland

Oral

2.2

7.3

323

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.9

7.3

497

L95

ICPC

Osteoporosis

1.6

7.2

160

984

H15.1

ICD-10 Finland

Episcleritis

2.3

7.2

265

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

7.2

1859

16563

J96.1

ICD-10 Finland

Chronic respiratory failure

1.8

7.2

108

591

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.1

7.2

364

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.9

7.2

106

577

D06BB04

ATC

podophyllotoxin; topical

1.6

7.2

168

1052

L30.0

ICD-10 Finland

Nummular dermatitis

1.7

7.2

151

917

N76.0

ICD-10 Finland

Acute vaginitis

1.6

7.1

182

1164

H26.2

ICD-10 Finland

Complicated cataract

2.3

7.1

279

2040A

ICD-9 Finland

Lymphoid leukaemia, Acute

20.0

7.1

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

4.8

7.1

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

7.1

988

8318

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

7.1

177

1126

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.8

7.1

115

646

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

7.1

474

3645

B73

ICPC

Leukaemia

6.6

7.1

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

7.1

271

1895

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

1.8

7.1

111

616

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

7.1

458

A76

ICPC

Viral exanthem other

2.9

7.1

143

R35

ICD-10 Finland

Polyuria

1.4

7.1

282

1986

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.4

7.1

223

M05BA06

ATC

ibandronic acid; systemic

1.9

7.1

103

557

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

7.1

431

HMAK

NOMESCO Finland

1.3

7.1

504

3913

XCK10

NOMESCO Finland

Photography of fundus of eye

1.3

7.1

490

3791

A03FA02

ATC

cisapride; oral, rectal

1.4

7.1

401

3008

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

7.0

290

2056

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.6

7.0

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.6

7.0

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.8

7.0

118

670

M01AH05

ATC

etoricoxib; oral

1.2

7.0

2911

26873

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.4

7.0

235

K92.1

ICD-10 Finland

Melaena

1.5

7.0

260

1807

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

7.0

210

1397

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

7.0

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.1

7.0

364

D01AC02

ATC

miconazole; topical

1.4

7.0

380

2835

J01DA06

ATC

[U] cefuroxime; systemic

1.3

7.0

672

5431

J47

ICD-10 Finland

Bronchiectasis

1.9

7.0

509

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

6.9

206

1363

L04AA17

ATC

[U] adalimumab; parenteral

3.8

6.9

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

1.7

6.9

121

697

I20.00

ICD-10 Finland

Unstable angina

1.6

6.9

162

1014

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

6.3

6.9

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

6.9

206

1368

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.8

6.9

102

557

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

7.5

6.9

S01AX11

ATC

[U] ofloxacin; ophthalmic

1.6

6.9

181

1168

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

6.9

847

7039

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

13.8

6.9

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.2

6.9

302

M79.7

ICD-10 Finland

Fibromyalgia

1.7

6.9

136

812

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.1

6.8

360

WX872

NOMESCO Finland

Intensive care

1.5

6.8

226

1536

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

3.8

6.8

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.8

979

8269

R06.2

ICD-10 Finland

Wheezing

1.5

6.8

191

1249

SPAT1240

SPAT

Therapeutic discussion

1.3

6.8

404

3054

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

6.8

203

1347

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

2.9

6.8

126

WW402

NOMESCO Finland

Leucoferesis

6.7

6.8

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

10.9

6.8

5602

FHL

Internal fistula (eg Cimino)

10.9

6.8

C10AC01

ATC

colestyramine; oral

1.7

6.8

118

681

Z00.8

ICD-10 Finland

Other general examinations

1.4

6.8

318

2312

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

6.8

152

940

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.1

6.8

366

E87.6

ICD-10 Finland

Hypokalaemia

1.6

6.8

144

881

XX4BW

NOMESCO Finland

6.1

6.8

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

6.8

235

1613

L04AB01

ATC

etanercept; parenteral

2.2

6.7

275

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

3.8

6.7

S01ED51

ATC

timolol, combinations; ophthalmic

1.4

6.7

379

2840

L04AB06

ATC

golimumab; parenteral

2.9

6.7

127

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.7

6.7

140

848

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

6.7

236

1621

R51

ICD-10 Finland

Headache

1.5

6.7

199

1321

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

6.7

461

3560

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.8

6.7

104

577

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

4.7

6.7

A02BC04

ATC

rabeprazole; oral

1.4

6.7

361

2690

KAS40

NOMESCO Finland

Excision of transplanted kidney

22.5

6.7

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.4

6.7

211

ZX140

NOMESCO Finland

Intra articular

2.7

6.7

160

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.5

6.6

186

1218

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

3.8

6.6

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.2

6.6

303

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.3

6.6

K12.10

ICD-10 Finland

Stomatitis NOS

3.1

6.6

106

WW400

NOMESCO Finland

Plasmaferesis

6.4

6.6

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.8

6.6

523

R06.4

ICD-10 Finland

Hyperventilation

2.1

6.6

338

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

2.2

6.6

283

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

5.1

6.6

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

2.7

6.6

162

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

6.6

157

987

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

5.9

6.6

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

5.5

6.6

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

6.6

513

4035

A99

ICPC

Disease/condition unspecnature/site

1.4

6.6

366

2737

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

6.6

157

990

I95.9

ICD-10 Finland

Hypotension, unspecified

2.1

6.6

353

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

6.5

L04AA11

ATC

[U] etanercept; parenteral

3.6

6.5

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.1

6.5

344

J04AB02

ATC

rifampicin; systemic

2.2

6.5

286

WX610

NOMESCO Finland

Patient controlled analgesia

3.3

6.5

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1.5

6.5

180

1176

I50

ICD-10 Finland

Heart failure

1.6

6.5

161

1023

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

4.8

6.5

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

4.3

6.5

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

6.5

186

1224

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.5

6.5

180

1177

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.1

6.5

102

1XX32

NOMESCO Finland

6.8

6.5

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

6.8

6.5

K06.10

ICD-10 Finland

Gingival fibromatosis

6.8

6.5

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

6.5

660

5369

S20.2

ICD-10 Finland

Contusion of thorax

1.5

6.5

201

1349

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.5

6.5

190

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.7

6.5

124

736

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.7

6.5

131

791

WX290

NOMESCO Finland

Other blockade of nerve

1.2

6.5

1882

16899

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

6.5

157

992

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.0

6.5

361

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.6

6.5

L01AA03

ATC

melphalan; systemic

4.5

6.4

A02BA04

ATC

nizatidine; systemic

1.3

6.4

390

2957

6119

FHL

Other measure in this category

69.9

6.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

6.4

298

2161

L03AA14

ATC

lipegfilgrastim; parenteral

1.9

6.4

413

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

6.4

120

708

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

4.2

6.4

H81

ICPC

Excessive ear wax

1.2

6.4

793

6594

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.6

6.4

167

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.6

6.4

167

R50.8

ICD-10 Finland

Other specified fever

3.2

6.4

L03AX13

ATC

glatiramer acetate; parenteral

3.9

6.4

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

6.3

187

1238

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

6.3

378

2859

JN6AD

NOMESCO Finland

CT of torso and neck

2.2

6.3

276

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

6.3

212

1447

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.3

6.3

235

TAC00

NOMESCO Finland

Peripheral nerve block

3.4

6.3

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

6.3

168

1088

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

6.3

338

2518

CBG00

NOMESCO Finland

Epilation of cilia by electrolysis

4.2

6.3

SPAT1252

SPAT

Overall medication plan or its review

1.4

6.3

347

2597

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

9.2

6.3

B59

ICD-10 Finland

Pneumocystosis

9.2

6.3

H17.8

ICD-10 Finland

Other corneal scars and opacities

4.6

6.3

C08DA01

ATC

verapamil; systemic

1.5

6.3

207

1408

0537A

ICD-9 Finland

Herpes zoster, With other specified complications[ZOSTER OTICUS]

+∞

6.2

05301

ICD-8 Finland

Herpes zoster, Oticus

+∞

6.2

B01.8

ICD-10 Finland

Varicella with other complications

+∞

6.2

05405

ICD-8 Finland

Herpes simplex, Kerato-conjunctivitis herpetica

+∞

6.2

0538A

ICD-9 Finland

Herpes zoster, With unspecified complication[HERPES ZOSTER GENERALISATUS]

+∞

6.2

05699

ICD-8 Finland

Rubella, Non definita

+∞

6.2

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

6.2

834

6991

R01AD01

ATC

beclometasone; nasal

1.2

6.2

679

5567

S01EA03

ATC

apraclonidine; ophthalmic

2.3

6.2

238

R06AX13

ATC

loratadine; oral

1.3

6.2

643

5241

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.7

6.2

146

G05.1

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere

26.7

6.2

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.0

6.2

366

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

4.1

6.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

6.2

361

2723

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

2.6

6.2

158

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

2.6

6.2

158

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.5

6.2

183

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

6.2

1359

11934

RS222

NOMESCO Finland

2.1

6.2

307

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.9

6.2

463

D02AX

ATC

Other emollients and protectives

1.6

6.1

136

841

XF402

NOMESCO Finland

ECG with work load test

1.3

6.1

526

4191

ZZR00

NOMESCO Finland

Flap of skin

1.7

6.1

114

673

D07XC01

ATC

betamethasone, combinations; topical

1.3

6.1

533

4252

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.4

6.1

194

C10AX09

ATC

ezetimibe; oral

1.3

6.1

481

3786

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.4

6.1

213

L15

ICPC

Knee symptom/complaint

1.2

6.1

979

8357

L60.0

ICD-10 Finland

Ingrowing nail

1.5

6.1

180

1195

AP4

Myocardial biopsy

7.7

6.1

M87.3

ICD-10 Finland

Other secondary osteonecrosis

7.7

6.1

K29

ICPC

Cardiovascular sympt/complt other

1.5

6.1

198

1343

C08CA02

ATC

felodipine; oral

1.3

6.1

472

3708

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

6.1

142

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.4

6.1

248

1761

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

2.7

6.1

136

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

4.6

6.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.7

6.1

125

757

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.6

6.1

142

893

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

6.1

578

4667

Z94.7

ICD-10 Finland

Corneal transplant status

3.8

6.1

134

Kela drug reimbursment

General erythroderma

3.8

6.1

318

Kela drug reimbursment

Teriparatide

3.0

6.1

108

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

270

204

13.70

287.45

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

2966

17331

2.19

218.02

5.7

4.2

—

(3006315) Basophils [#/volume] in Blood

4332

29470

2.13

212.16

9.7

5.6

0.0

e9/l

0.33

3862

25107

(3001604) Monocytes [#/volume] in Blood

4309

29309

2.13

210.40

9.7

5.6

0.6

e9/l

0.69

3843

24963

(3013115) Eosinophils [#/volume] in Blood

4419

30451

2.12

207.06

10.2

5.8

0.2

e9/l

0.63

3986

26351

(3019198) Lymphocytes [#/volume] in Blood

4370

30134

2.10

202.45

9.8

5.6

2.0

1.9

e9/l

1.20

3951

26152

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

469

1038

4.76

196.77

8.2

4.6

431.2

3217.4

iu/ml

0.81

135

(3006504) Eosinophils/100 leukocytes in Blood

4064

27591

2.05

192.53

10.2

5.8

2.8

0.39

3829

25468

(3022096) Basophils/100 leukocytes in Blood

3973

26784

2.04

191.59

10.2

5.9

0.7

0.15

3737

24760

(3019069) Monocytes/100 leukocytes in Blood

4077

27758

2.04

191.06

10.7

6.1

8.9

8.7

3.94

3846

25741

(42870588) Differential panel, method unspecified - Blood

3238

20292

2.06

191.05

9.7

5.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4761

34327

2.09

189.98

14.7

8.7

4.2

e9/l

0.18

4307

29719

(3002030) Lymphocytes/100 leukocytes in Blood

4134

28408

2.03

187.32

10.4

5.9

27.0

27.2

0.49

3882

26177

(3018010) Neutrophils/100 leukocytes in Blood

4072

27991

2.01

182.44

9.8

5.7

57.7

57.8

0.23

3824

25916

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

293

466

6.51

176.09

1.2

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4401

31813

1.95

162.08

9.2

5.9

10.9

11.7

umol/l

3.91

4201

30062

(3011412) CD3 cells [#/volume] in Blood

285

501

5.88

154.71

2.8

2.3

1.1

e9/l

0.58

178

297

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1443

7145

2.27

151.29

6.6

4.0

247.5

246.5

u/l

0.08

1370

6702

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4333

31634

1.89

149.34

10.4

6.5

1.2

mmol/l

0.08

3655

26474

(21494815) CD4 cells/100 lymphocytes in Specimen

257

424

6.24

148.83

2.6

2.2

35.5

40.0

0.62

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1886

10436

2.08

148.66

2.4

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

359

809

4.61

146.80

3.7

2.4

3146.9

2050.0

u/ml

0.19

(3010375) cycloSPORINE [Mass/volume] in Blood

170

182

9.54

143.23

36.3

22.1

107.4

115.3

ug/l

0.73

154

144

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3974

28645

1.84

138.09

9.2

5.8

1.2

mmol/l

0.19

3621

25712

(3005719) IgG [Mass/volume] in Serum or Plasma

970

4212

2.50

135.99

4.2

2.6

9.6

10.6

g/l

7.73

908

3822

(3013826) Glucose [Moles/volume] in Serum or Plasma

4723

36118

1.85

133.11

7.1

4.6

6.8

mmol/l

0.10

4522

33761

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

230

384

6.15

131.54

2.4

2.0

13.6

14.1

0.16

110

161

(3001964) Herpes simplex virus Ag [Presence] in Specimen

136

122

11.34

129.73

1.6

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

231

395

6.00

128.93

2.5

2.0

74.1

72.3

0.77

221

376

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

217

349

6.38

128.81

3.1

2.4

717.0

667.7

e6/l

0.27

153

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

222

366

6.22

128.58

2.5

1.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5713

46694

1.98

128.07

12.5

7.3

79.2

79.5

u/l

0.18

5458

43687

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1479

8032

2.05

119.32

9.1

5.4

1.1

1.0

mmol/l

2.43

1385

7370

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

204

343

6.09

115.80

2.9

2.5

570.3

499.8

e6/l

0.77

166

286

(3024561) Albumin [Mass/volume] in Serum or Plasma

3710

27106

1.74

114.57

7.3

4.6

34.7

35.1

g/l

3.20

3431

24971

(3013707) Erythrocyte sedimentation rate by Westergren method

5428

44313

1.84

112.84

6.4

4.1

15.0

13.3

mm/h

12.20

5048

40635

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1599

9122

1.96

111.29

3.2

2.4

2.3

g/l

1.97

1489

8356

(3027945) Reticulocytes/100 erythrocytes in Blood

1359

7325

2.05

111.11

3.8

2.5

1.9

1.8

2.66

1206

6397

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

195

327

6.10

110.98

3.0

2.5

0.2

e9/l

0.41

164

284

(3022948) Iron [Moles/volume] in Serum or Plasma

1686

9873

1.92

108.15

3.2

2.4

12.1

12.5

umol/l

1.40

1556

9049

(3028026) IgM [Mass/volume] in Serum or Plasma

770

3329

2.47

107.74

2.8

1.8

1.5

1.4

g/l

0.26

694

2998

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2807

19201

1.74

107.66

3.8

3.1

1857.5

1639.9

ng/l

1.12

2450

16550

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1323

7182

2.03

105.52

2.2

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

1085

5474

2.15

105.28

3.6

2.5

72.2

69.1

e9/l

1.90

846

4121

(3017181) Myelocytes/100 leukocytes in Blood

1024

5056

2.19

104.93

5.8

4.0

0.9

0.12

399

1450

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1498

8511

1.95

104.76

3.3

2.5

21.5

21.9

0.62

1295

7148

(3007853) Bacteria identified in Skin by Aerobe culture

1295

7007

2.03

104.10

2.0

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5058

40862

1.75

103.77

6.4

4.8

1547.0

2322.6

e6/l

0.43

595

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1314

7167

2.01

103.20

2.3

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

964

4697

2.21

101.92

2.0

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1676

10043

1.86

98.91

5.2

3.1

0.8

mmol/l

2.32

1573

9279

(3037467) Urinalysis macro (dipstick) panel - Urine

5129

41950

1.73

96.73

6.5

4.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2758

19220

1.69

95.87

3.2

2.5

58.0

58.3

u/l

0.09

2570

17617

(3002179) Metamyelocytes/100 leukocytes in Blood

931

4597

2.17

94.79

5.3

3.8

0.7

0.6

0.10

288

1041

(3021440) Promyelocytes/100 leukocytes in Blood

961

4815

2.14

94.23

5.8

4.0

0.2

0.1

0.33

375

1347

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2399

16199

1.71

93.12

2.7

2.3

3.2

3.0

mg/l

2.94

2066

13746

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3267

23954

1.65

92.33

5.2

3.9

49.0

91.5

ng/l

1.13

2554

17209

(3042936) Bacteria identified in Isolate by Culture

1467

8597

1.88

92.03

2.3

2.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

417

1427

3.04

91.69

2.1

1.5

—

(3032080) INR in Blood by Coagulation assay

3460

25792

1.64

91.17

12.0

9.8

1.3

inr

0.77

986

7196

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

163

279

5.95

90.82

3.5

2.4

38.1

39.2

0.16

107

(3021589) Normoblasts [#/volume] in Blood

3475

26002

1.63

89.65

15.7

9.7

0.0

e9/l

0.52

2977

21102

(3018418) pH of Serum or Plasma

2679

18786

1.67

89.28

6.8

3.9

7.4

0.71

548

3534

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

399

1375

3.01

86.59

2.2

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

241

610

4.05

84.42

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1032

5516

2.01

84.41

11.4

6.6

11.2

10.4

mmol/l

2.29

975

5211

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

330

1033

3.30

84.25

2.2

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

102

113

9.14

83.68

2.6

1.8

132.2

143.5

e6/l

0.16

(3014148) Varicella zoster virus Ab [Titer] in Serum

225

552

4.17

82.20

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6586

58978

2.06

81.94

27.3

15.2

22.5

24.8

mg/l

7.85

5771

47312

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2667

19002

1.63

81.55

2.6

2.1

188.8

218.5

u/l

0.92

2518

17724

(3002582) Erythrocytes [#/volume] in Urine

2655

18899

1.63

81.46

4.8

3.3

44.0

89.8

e6/l

3.52

2179

14460

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

656

2978

2.32

81.38

1.9

1.7

1.5

g/l

0.43

573

2523

(3018095) Leukocytes [#/volume] in Urine

2986

21912

1.61

80.62

5.4

3.8

88.9

109.7

e6/l

0.97

2299

15531

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

429

1599

2.79

80.56

2.6

1.5

0.2

g/l

2.60

403

1497

(3026008) Bacteria identified in Urine by Culture

2811

20334

1.62

80.52

4.0

3.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3353

25325

1.59

79.96

2.8

2.2

79.8

78.6

nmol/l

1.26

2997

22400

(3006245) CD3-CD19+ cells/100 cells in Blood

120

172

7.07

79.40

2.6

1.9

9.3

10.7

0.52

105

161

(3025159) Blasts/100 leukocytes in Blood

877

4513

2.07

79.35

5.8

4.0

0.1

0.4

1.35

311

1128

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

316

1001

3.25

79.09

1.7

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

435

1650

2.74

78.97

2.6

1.5

1.2

g/l

1.26

416

1541

(3020630) Protein [Mass/volume] in Serum or Plasma

999

5397

1.98

78.90

3.9

2.5

65.4

66.2

g/l

2.16

909

4814

(3030467) Casts [#/volume] in Urine by Automated count

2467

17353

1.63

78.78

4.5

3.2

0.4

0.5

e6/l

0.50

1979

13065

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

120

174

6.99

78.57

2.7

1.9

33.7

29.0

1.82

111

166

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

184

401

4.68

78.19

1.9

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

402

1472

2.83

78.03

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1042

5738

1.95

77.77

1.9

1.5

—

(40758558) Short blood count panel - Blood

2202

15100

1.65

77.55

11.4

6.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1951

12988

1.68

76.95

2.2

1.7

1.4

1.3

mg/l

0.22

1516

9987

(3026493) Urate [Moles/volume] in Serum or Plasma

2264

15681

1.64

76.40

4.3

2.6

3724.5

5295.8

umol/l

1.14

1966

13328

(40760892) CBC W Ordered Manual Differential panel - Blood

1873

12372

1.69

75.91

7.6

4.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

274

815

3.45

75.82

2.0

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1367

8273

1.80

75.62

1.9

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

268

791

3.48

75.06

1.7

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

117

174

6.82

74.83

31.0

33.0

7.2

7.5

ug/l

0.58

160

(3000850) Epithelial cells [#/volume] in Urine

1974

13294

1.66

73.96

3.6

2.6

5.9

5.7

e6/l

0.10

1775

11581

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

743

3699

2.12

73.11

1.7

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1534

9689

1.74

72.87

2.6

2.0

29.7

29.8

0.44

1485

9379

(3036481) Cortisol [Moles/volume] in Serum or Plasma

973

5345

1.94

72.81

2.3

2.2

361.4

378.9

nmol/l

1.64

895

4889

(3026782) Osmolality of Urine

1867

12445

1.67

72.55

4.0

2.8

525.8

543.2

mosm/kgh2o

3.03

1662

10539

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1040

5854

1.90

72.29

5.2

3.7

5.9

5.8

kpa

0.35

1011

5665

(3004588) Protein electrophoresis panel - Serum or Plasma

848

4478

2.01

71.02

3.8

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3298

25280

1.55

70.66

3.8

2.8

173.1

132.1

ug/l

4.19

3031

23093

(3021879) Hepatitis B virus core Ab [Presence] in Serum

733

3684

2.10

70.23

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

235

668

3.60

69.69

2.0

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

3741

29541

1.54

69.58

5.1

3.9

0.0

estimate

1.08

785

5436

(3002032) Base excess in Venous blood by calculation

1028

5842

1.88

69.16

5.3

3.7

1.9

mmol/l

0.09

856

4731

(3012544) pH of Venous blood

1056

6060

1.87

68.88

5.2

3.7

7.4

0.43

(3044640) Blood type and Crossmatch panel - Blood

2661

19534

1.57

68.57

3.4

2.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

3742

29629

1.53

68.17

6.9

5.2

0.0

estimate

0.80

796

5482

(3009261) Glucose [Presence] in Urine by Test strip

3770

29958

1.53

67.12

5.2

3.9

0.0

estimate

1.72

777

5383

(3028433) Virus identified in Specimen by Culture

112

181

6.27

66.15

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3597

28371

1.52

65.82

5.3

4.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1270

7823

1.75

65.12

8.2

6.5

104.1

104.3

mmol/l

0.70

1233

7640

(36304419) Bacteria [Presence] in Urine

2336

16803

1.57

64.98

4.4

3.2

—

(3000991) Gas panel - Venous blood

914

5167

1.88

62.06

9.0

7.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2086

14837

1.57

59.96

3.1

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

293

1044

2.88

59.70

2.0

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1595

10700

1.63

58.52

2.0

1.4

2.3

2.5

g/l

1.73

1025

6250

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3330

26273

1.49

58.12

2.2

2.0

93.4

95.0

pmol/l

1.08

1746

13332

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2506

18673

1.52

57.73

4.7

3.1

34.7

u/l

0.00

2369

17602

(3024354) Oxygen [Partial pressure] in Venous blood

853

4821

1.87

57.72

4.4

3.1

4.5

kpa

0.17

828

4641

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

862

4900

1.86

57.25

5.0

3.5

101.8

91.2

ng/l

2.08

729

4128

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

129

6.89

57.06

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1579

10630

1.62

56.88

3.7

2.8

1.3

1.5

e6/l

0.38

1014

6050

(3000494) Fungus identified in Specimen by Culture

1104

6768

1.74

56.88

1.8

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

264

922

2.93

55.78

1.5

1.4

109.8

120.4

u/ml

0.70

189

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1150

7167

1.72

55.75

1.8

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

285

1038

2.82

55.74

1.5

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2796

21433

1.49

55.55

4.4

3.3

2.3

2.4

mmol/l

2.42

2394

18396

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

284

1039

2.80

55.08

1.5

1.4

19.8

18.8

u/ml

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6637

61065

1.84

54.86

28.9

17.8

139.4

139.6

mmol/l

7.34

6501

59429

(21494814) CD8 cells/100 lymphocytes in Specimen

112

218

5.20

54.39

2.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

924

5456

1.79

54.01

7.1

6.4

1.3

1.4

mmol/l

0.84

881

5249

(3033658) Prothrombin time (PT) actual/Normal

2110

15330

1.53

53.93

5.5

3.8

88.7

88.2

0.42

2057

14938

(3004809) Band form neutrophils/100 leukocytes in Blood

280

1030

2.79

53.74

4.6

3.5

1.2

1.6

1.07

235

783

(3037692) Legionella sp identified in Specimen by Organism specific culture

101

182

5.61

53.37

1.7

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

520

2539

2.13

53.29

2.1

1.6

12.4

18.2

u/ml

0.56

(3023103) Potassium [Moles/volume] in Serum or Plasma

6640

61196

1.83

53.24

29.3

18.0

4.0

mmol/l

3.20

6499

59448

(3037522) Nuclear Ab [Titer] in Serum

1178

7493

1.68

52.65

1.5

1.3

640.1

515.0

titre

1.21

273

1624

(3009343) pH of Capillary blood

717

3951

1.90

52.23

4.8

3.6

7.4

0.07

492

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

724

4004

1.90

52.16

4.9

3.6

5.1

5.2

kpa

3.02

662

3664

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1086

6775

1.71

52.16

4.4

2.6

7.6

8.8

umol/l

1.27

968

5829

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

275

4.57

51.63

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

132

309

4.33

51.33

1.2

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2074

15144

1.51

51.26

1.7

1.6

20.5

20.4

nmol/l

0.13

1796

12828

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

270

999

2.77

51.24

1.3

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

693

3808

1.90

50.87

4.7

3.6

1.4

1.9

mmol/l

2.74

510

2823

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1462

9891

1.60

50.86

4.0

3.0

3.1

2.7

e6/l

0.72

902

5370

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

451

2125

2.20

50.56

3.0

2.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

520

2590

2.08

50.51

2.3

1.9

5.6

2.2

ug/l

0.62

461

2243

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

257

937

2.81

50.16

1.3

1.2

279.0

267.2

u/ml

0.26

170

561

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1747

12368

1.54

49.60

4.9

3.9

336.1

423.0

ng/l

0.32

1416

10063

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

247

887

2.85

49.59

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4010

33437

1.44

48.85

3.1

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

226

780

2.96

48.78

1.6

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

260

4.56

48.61

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

342

1462

2.40

48.19

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6073

54989

1.58

48.09

22.9

14.4

75.3

77.5

ml/min/173m2

10.64

5292

45368

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

695

3894

1.87

47.92

1.9

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

191

608

3.20

47.39

2.2

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1329

8938

1.59

46.97

29.1

27.1

1.4

inr

0.36

181

1259

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

316

1325

2.45

46.45

1.7

1.3

575.3

531.0

mg/l

0.86

305

1249

(3028679) Herpes simplex virus Ab [Presence] in Serum

109

239

4.61

46.05

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.70

45.63

2.2

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5166

45412

1.46

45.43

4.5

4.1

15.0

14.9

pmol/l

1.42

4644

40830

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1121

7293

1.63

45.28

7.7

6.7

5.0

5.1

kpa

1.10

1076

6937

(3037756) Immunofixation for Serum or Plasma

321

1374

2.40

45.08

2.2

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

411

1953

2.17

45.04

1.5

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1119

7289

1.63

44.95

7.7

6.7

11.7

12.2

kpa

2.71

1076

6927

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

177

563

3.20

43.99

2.2

1.7

—

(44806118)

191

636

3.06

43.93

2.1

1.3

—

(44790049)

191

636

3.06

43.93

2.1

1.3

—

(44790048)

191

636

3.06

43.93

2.1

1.3

—

(44790047)

191

636

3.06

43.93

2.1

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

179

5.13

43.71

2.2

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

268

1076

2.55

43.21

1.7

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1763

12820

1.49

43.10

1.9

1.8

1184.5

1169.0

nmol/l

0.27

1323

9532

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.52

42.91

4.5

5.9

—

(3003396) Base excess in Arterial blood by calculation

1108

7279

1.61

42.81

7.7

6.7

1.2

1.1

mmol/l

0.34

903

5651

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

158

477

3.36

42.75

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

282

1167

2.47

42.65

1.7

1.3

3.7

3.8

mmol/l

0.45

265

1084

(3045142) Bone marrow Pathology biopsy report

197

679

2.95

42.64

1.6

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

182

4.99

41.90

2.3

2.0

685.8

76013.4

u/ml

—

(40768804) Tissue Pathology biopsy report

3009

24266

1.40

41.76

2.4

2.1

—

(3042733) HLA Ab [Presence] in Serum

126

5.92

41.53

5.5

5.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

161

502

3.26

41.37

2.3

2.4

—

(3016502) Oxygen saturation in Arterial blood

1008

6527

1.63

41.19

8.1

7.0

95.5

95.6

0.07

975

6265

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

330

1491

2.27

40.90

5.9

3.2

1.8

1.6

mg/l

4.54

305

1338

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

540

2935

1.91

40.71

5.8

3.9

24.3

24.2

mmol/l

0.30

475

2627

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

423

2115

2.06

40.52

6.0

3.1

36.5

50.4

mg/l

1.20

349

1725

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

914

5800

1.66

40.41

2.4

2.1

0.2

g/l

0.95

852

5375

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5956

54247

1.50

40.24

5.5

4.9

2.0

2.1

mu/l

0.90

5447

49108

(3034860) Kappa light chains.free [Mass/volume] in Serum

422

2116

2.05

40.11

6.0

3.1

81.8

83.8

mg/l

0.02

345

1730

(40761511) CBC panel - Blood by Automated count

6532

60751

1.64

40.00

23.2

14.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6659

62244

1.70

39.92

17.2

10.6

25.2

25.3

u/l

0.14

6428

59693

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

412

2062

2.06

39.35

5.9

3.1

2.7

2.4

ratio

0.20

153

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

523

2849

1.90

39.12

3.6

2.7

0.7

0.81

501

2733

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2814

22648

1.39

38.56

5.6

4.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

272

1170

2.38

37.78

1.8

1.4

18.3

26.4

e6/l

0.52

209

903

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

158

515

3.11

37.73

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

272

1171

2.37

37.71

1.9

1.5

338.3

1266.7

e6/l

2.03

219

955

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

341

1614

2.17

37.69

2.4

1.4

14.6

17.6

iu/ml

0.18

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

475

2537

1.93

37.69

3.9

2.2

7.3

7.5

g/l

0.94

335

1864

(40760888) Immunoglobulin light chains.free panel - Serum

336

1585

2.17

37.45

5.9

3.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

473

2534

1.93

37.18

3.9

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

186

671

2.82

37.07

5.3

4.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

2532

1.92

36.95

3.9

2.2

3.7

3.8

g/l

0.20

315

1791

(3024471) HLA-A [Type]

145

5.21

36.77

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

881

5667

1.63

36.70

2.9

2.4

43.5

46.5

u/l

0.09

770

4822

(3024932) HLA-DR beta [Type]

139

5.29

36.41

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

2087

16093

1.41

36.20

5.7

4.3

0.0

estimate

0.16

766

5291

(3004119) Hemoglobin [Mass/volume] in Venous blood

641

3807

1.75

36.04

4.2

3.3

125.1

127.8

g/l

2.36

626

3706

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2368

1.94

35.99

3.8

2.2

3.1

g/l

0.03

318

1829

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4263

36917

1.37

35.95

4.0

3.0

59.0

49.9

u/l

5.10

3951

33910

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

415

2152

1.98

35.87

3.8

2.3

1.6

0.9

g/l

1.89

351

1821

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

342

1655

2.12

35.70

3.5

2.4

3.4

3.6

g/l

1.47

332

1568

(40761535) Cells panel - Urine sediment

827

5276

1.64

35.54

5.3

3.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

390

1987

2.02

35.43

1.8

1.6

289.5

271.0

titre

0.05

(3011397) Hemoglobin [Presence] in Urine by Test strip

1875

14258

1.42

34.97

4.9

3.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

153

512

3.03

34.94

2.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

153

512

3.03

34.94

2.1

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

153

512

3.03

34.94

2.1

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1349

9641

1.49

34.93

1.3

63.7

34.9

iu/ml

0.65

424

2976

(3002173) Hemoglobin [Mass/volume] in Arterial blood

911

5997

1.59

34.35

8.6

7.4

117.7

120.3

g/l

3.38

884

5776

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

354

1765

2.06

34.13

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

164

4.73

33.77

3.5

3.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

141

461

3.10

33.53

2.3

1.8

3.7

4.3

mg/l

1.07

131

439

(3027273) Bicarbonate [Moles/volume] in Venous blood

537

3103

1.79

33.12

4.3

3.3

25.3

25.2

mmol/l

0.26

527

3011

(3005322) IgE [Units/volume] in Serum or Plasma

552

3219

1.77

32.99

1.5

1.3

367.7

205.9

u/ml

1.68

500

2952

(4035726)

839

5475

1.60

32.73

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

543

3169

1.77

32.35

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

284

1333

2.18

32.06

1.8

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

254

1144

2.26

31.73

5.5

3.6

56.5

58.2

0.99

254

1144

(3022313) Gas panel - Capillary blood

498

2855

1.80

31.51

5.0

3.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

336

1696

2.03

31.31

1.6

6.5

5.8

iu/ml

0.03

391

(3007461) Platelets [#/volume] in Blood

6820

64732

1.69

31.27

37.6

22.4

244.8

248.9

e9/l

5.20

6669

62860

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

478

2713

1.81

31.26

2.4

2.0

—

(3010813) Leukocytes [#/volume] in Blood

6823

64771

1.69

31.22

37.6

22.4

7.1

6.8

e9/l

4.11

6664

62671

(3016018) Differential panel - Cerebral spinal fluid

156

562

2.81

31.22

1.5

1.4

—

(4062490)

150

531

2.86

31.02

1.5

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

6822

64774

1.68

31.00

37.8

22.5

130.7

133.6

g/l

47.62

6723

63677

(3019060) Gas panel - Arterial blood

681

4276

1.65

30.98

5.3

4.7

—

(3035941) MCH [Entitic mass]

6820

64753

1.68

30.96

37.4

22.3

30.4

30.3

1.56

6724

63636

(3024731) MCV [Entitic volume]

6820

64753

1.68

30.96

37.4

22.3

91.7

91.2

11.50

6723

63637

(3026361) Erythrocytes [#/volume] in Blood

6820

64760

1.68

30.85

37.6

22.4

4.3

4.4

e12/l

41.63

6665

62672

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

398

2141

1.91

30.84

2.4

2.2

447.0

607.6

ug/l

0.56

363

2015

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

143

499

2.90

30.36

1.8

1.5

—

(3013512) EKG study

2286

18332

1.36

30.00

5.2

4.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

444

2495

1.83

29.99

2.1

1.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

331

1690

2.00

29.88

2.9

1.6

—

(40768446) Kidney Pathology biopsy report

194

4.16

29.83

1.8

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

608

3754

1.67

29.48

2.4

18.8

24.3

au/ml

0.68

174

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

856

5744

1.55

29.43

2.7

2.4

6.9

6.8

ug/l

0.05

716

4877

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

425

2378

1.84

29.10

4.0

2.2

10.2

g/l

0.00

342

1973

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

800

5303

1.57

29.01

5.8

3.7

1.2

mmol/l

0.43

731

4586

(3028626) Oxygen [Partial pressure] in Capillary blood

292

1447

2.06

28.63

3.6

3.0

8.1

8.0

kpa

0.36

273

1334

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

434

2465

1.81

28.29

5.3

3.9

24.5

24.9

mmol/l

1.58

397

2236

(3028192) IgG subclass 2 [Mass/volume] in Serum

145

530

2.77

28.27

1.5

1.3

2.4

2.9

g/l

3.48

113

361

(3024139) IgG subclass 3 [Mass/volume] in Serum

145

530

2.77

28.27

1.5

1.3

0.3

0.4

g/l

2.21

112

362

(3027135) IgG subclass 1 [Mass/volume] in Serum

145

531

2.77

28.18

1.5

1.3

6.0

6.9

g/l

1.82

114

361

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.87

27.37

1.2

1.4

—

(3023419) Bacteria identified in Sputum by Culture

181

752

2.44

27.22

2.7

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

277

1374

2.06

27.09

1.5

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

553

3405

1.67

27.04

1.3

91.7

51.8

au/ml

0.83

148

(3022145) Colonoscopy Study observation

938

6540

1.50

26.82

1.4

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

312

1624

1.96

26.66

4.0

3.1

24.2

25.1

mmol/l

2.95

277

1410

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

398

2248

1.81

26.41

3.5

2.9

0.3

u/ml

0.24

243

1273

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

16.97

26.33

2.5

2.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5848

54199

1.38

26.32

7.0

6.0

40.7

40.1

mmol/mol

5.28

5332

49548

(3048689) Calprotectin [Mass/mass] in Stool

947

6646

1.49

26.18

3.0

2.1

142.2

142.5

ug/g

0.01

739

5179

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

276

1386

2.03

26.11

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

276

1386

2.03

26.11

1.4

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

617

3941

1.62

26.08

9.4

8.3

0.7

1.64

612

3907

(3023410) Appearance of Cerebral spinal fluid

135

497

2.75

26.00

2.1

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

5250

47909

1.33

25.87

30.9

18.5

14.0

13.8

21.59

5178

46781

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

412

2368

1.78

25.79

2.2

1.8

37.9

38.6

u/l

0.28

354

2062

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

185

797

2.35

25.68

6.2

6.3

11.9

12.0

mg/l

0.08

167

727

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

4.38

25.65

1.3

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

929

6524

1.48

25.56

4.6

3.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

616

3953

1.61

25.52

9.3

8.2

1.4

1.3

0.45

611

3922

(3041096) Erythrocytes [Presence] in Urine by Automated

1953

15592

1.34

25.51

4.8

3.6

—

(3009508) Creatinine [Moles/volume] in Urine

2329

19077

1.32

25.48

4.0

3.1

7.1

7.2

mmol/l

0.51

1947

15837

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

209

3.76

25.40

3.3

2.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1229

9110

1.42

25.36

1.3

1.2

15.6

13.7

u/ml

0.19

401

3400

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

378

2.99

25.31

1.8

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

288

1486

1.98

25.24

2.3

1.9

12.0

11.8

mg/l

0.16

267

1359

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

152

607

2.54

24.90

2.9

3.1

—

(3012516) Albumin [Mass/volume] in Urine

2226

18165

1.32

24.87

4.1

3.2

664.2

360.0

mg/l

1.67

1502

11273

(21494890) Protein electrophoresis panel - 24 hour Urine

158

644

2.48

24.79

3.6

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2335

19189

1.32

24.79

4.8

3.9

14.0

9.3

mg/mmol

3.18

1551

11885

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1989

1.84

24.77

3.6

2.1

37.4

g/l

0.02

299

1672

(3017354) Segmented neutrophils/100 leukocytes in Blood

157

641

2.48

24.55

4.2

3.5

55.6

59.3

1.13

109

397

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

16.20

24.55

2.2

2.7

—

(3019225) pH of Specimen

918

6500

1.47

24.15

6.0

4.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

342

1897

1.84

24.07

4.0

2.2

0.1

0.0

g/l

0.28

316

1713

(3015171) Extractable nuclear Ab [Units/volume] in Serum

380

2178

1.78

24.01

1.3

1.2

0.2

1.2

u/ml

3.14

205

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

292

1544

1.93

23.83

3.5

2.4

200.2

197.6

0.18

279

1470

(40768797) Stomach Pathology biopsy report

1123

8278

1.42

23.77

1.3

1.2

—

(3036489) Thrombin time

372

2129

1.79

23.62

2.8

2.0

22.1

21.4

0.90

340

1880

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

153

4.14

23.52

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1736

13764

1.34

23.41

1.7

22597305.9

27970471.1

pmol/l

0.15

1394

11212

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

519

3261

1.64

23.39

9.3

8.5

24.5

24.4

mmol/l

0.31

477

3027

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

236

1166

2.06

23.36

1.4

1.2

66.0

191.0

titre

—

(3052851) Hemolysis interference index of Serum or Plasma

343

1926

1.82

23.21

3.8

3.3

—

(3037121) Protein [Mass/volume] in Urine

376

2173

1.77

23.10

5.1

2.8

0.3

g/l

0.06

195

863

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

302

1632

1.89

23.08

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

334

3.02

23.05

1.9

1.5

—

(3017732) Neutrophils [#/volume] in Blood

614

4033

1.57

22.98

3.6

3.0

4.0

4.1

e9/l

0.86

433

3016

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

271

3.24

22.56

1.4

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

287

3.16

22.45

5.6

3.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

187

858

2.21

22.42

1.6

0.4

0.8

g/l

9.49

147

639

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

335

2.98

22.31

1.9

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

274

1452

1.92

22.23

2.7

2.2

123.8

127.3

g/l

1.11

190

1049

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

305

3.08

22.13

2.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

305

3.08

22.13

2.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

305

3.08

22.13

2.4

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

305

3.08

22.13

2.4

1.9

—

(1616796) Gas panel - Central venous blood

267

1412

1.92

21.80

5.2

3.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

612

4074

1.55

21.56

8.1

6.7

24.9

24.6

mmol/l

1.17

576

3799

(3029634) Reagin Ab [Titer] in Serum by VDRL

154

662

2.35

21.55

2.7

1.9

16.1

3.5

titre

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.98

21.54

3.4

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

273

1461

1.90

21.51

1.8

1.6

19890.6

12403.0

e6/l

1.03

212

1039

(3023420) DNA double strand Ab [Units/volume] in Serum

138

567

2.46

21.34

2.5

1.4

26.7

23.6

iu/ml

0.17

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6067

57049

1.35

21.09

5.3

4.7

6.0

mmol/l

2.82

5480

51321

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

144

4.05

21.05

3.9

3.4

7.5

7.6

mg/l

0.03

122

(3042631) Mycobacterium sp identified in Specimen

184

862

2.16

20.97

2.9

2.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

111

4.53

20.96

2.8

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

114

431

2.67

20.93

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1561

12360

1.33

20.88

1.3

1.9

1.8

u/ml

0.07

381

3194

(3044889) 12 lead EKG panel

4601

41737

1.27

20.88

4.8

4.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

301

1679

1.83

20.83

3.2

2.2

93.0

90.8

0.87

291

1570

(3003181) Sodium [Moles/volume] in Urine

228

1162

1.99

20.75

1.4

1.3

58.1

62.8

mmol/l

1.11

188

932

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

146

4.00

20.67

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

231

1185

1.98

20.64

3.5

2.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

142

4.04

20.60

1.3

1.1

—

(3021788) Differential panel - Synovial fluid

216

1084

2.02

20.53

1.7

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.52

20.50

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

134

4.13

20.48

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

307

1736

1.80

20.31

4.0

2.3

0.0

g/l

0.00

286

1586

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

130

535

2.46

20.06

1.2

1.1

—

3.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

229

1183

1.97

20.06

1.5

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5831

54623

1.32

19.98

4.5

4.0

1.3

mmol/l

5.62

5248

49152

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1771

1.78

19.82

3.9

2.2

0.0

g/l

0.50

286

1594

(3016650) Hepatitis A virus Ab [Presence] in Serum

181

863

2.12

19.74

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

186

898

2.10

19.64

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

143

3.94

19.59

1.3

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

306

2.93

19.55

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

306

2.93

19.55

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

498

3253

1.57

19.04

4.2

2.8

0.3

e6/l

0.15

489

3181

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

805

5807

1.43

18.95

3.6

3.0

247.4

219.7

ng/l

0.42

728

5294

(3012501) Base excess in Blood by calculation

258

1415

1.85

18.87

5.3

4.2

2.6

2.7

mmol/l

0.07

193

962

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

209

3.32

18.78

1.2

1.1

2101.1

1619.8

miu/ml

1.97

209

(40767503) Oxygen content in Capillary blood by calculation

249

1354

1.87

18.71

3.5

2.5

15.6

16.0

1.03

140

704

(3028271) Lactate [Moles/volume] in Capillary blood

199

1005

2.01

18.62

2.2

1.9

1.6

1.7

mmol/l

0.85

194

982

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

134

581

2.33

18.45

2.4

1.6

4363.6

1053.3

titre

0.88

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.60

18.40

1.4

1.1

—

(3020891) Body temperature

405

2539

1.63

18.39

5.6

4.5

—

(3010421) pH of Blood

289

1654

1.78

18.39

5.3

4.1

7.4

0.31

256

1382

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

513

3406

1.54

18.24

10.6

9.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

188

940

2.03

18.10

2.2

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1618

13103

1.30

18.03

5.6

4.4

1.0

kg/l

0.26

236

2058

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

257

1429

1.83

18.00

1.4

1.2

12.6

5.2

u/ml

0.78

147

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

120

502

2.41

17.92

1.7

1.6

30.8

22.8

u/ml

0.66

110

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

274

1557

1.79

17.87

1.4

1.2

63.6

46.6

u/ml

0.37

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

3.63

17.78

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

421

2690

1.60

17.69

5.7

5.0

1.6

0.15

403

2521

(40768443) Skin Pathology biopsy report

424

2715

1.60

17.65

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

291

2.87

17.64

2.6

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

257

1445

1.81

17.37

1.4

1.2

8.3

6.6

u/ml

0.31

228

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1486

11960

1.30

17.24

3.7

3.0

2.5

mmol/l

0.61

1305

10382

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

110

453

2.45

17.02

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

149

3.64

16.97

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

106

4.17

16.68

1.7

1.6

64.7

133.3

au/ml

0.60

(3020876) Protein [Mass/time] in 24 hour Urine

121

525

2.33

16.67

2.5

1.9

0.5

1.3

g/24h

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

3.50

16.57

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

217

1176

1.87

16.52

1.3

1.2

3.4

4.4

u/ml

0.18

(3024891) Influenza virus A+B Ag [Presence] in Specimen

254

1445

1.78

16.52

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

241

1353

1.81

16.39

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.42

16.24

3.8

5.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

163

807

2.04

16.16

1.7

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.82

16.15

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

410

2665

1.57

16.02

5.8

5.0

0.8

0.9

1.74

391

2499

(3005988) Vibrio sp identified in Specimen by Organism specific culture

163

810

2.04

16.01

1.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

670

4817

1.43

15.98

3.6

2.7

56.0

63.4

ml/min/173m2

5.21

303

1959

(3025468) Yersinia sp identified in Specimen by Organism specific culture

162

804

2.04

15.96

1.7

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6149

58458

1.31

15.93

5.5

5.0

2.6

2.7

mmol/l

8.10

5570

53161

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.95

15.90

1.3

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

195

1035

1.91

15.85

1.3

1.2

—

(3017704) Immunofixation for Urine

338

2.62

15.77

2.1

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

164

824

2.01

15.63

1.7

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

128

585

2.21

15.62

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

302

1833

1.68

15.59

1.5

1.4

273.2

270.4

ug/g

0.08

173

1086

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

161

805

2.02

15.56

1.7

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6018

57102

1.29

15.46

5.0

4.5

4.6

mmol/l

7.55

5483

52200

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

159

794

2.02

15.42

3.7

2.2

32.5

32.6

0.16

159

786

(3039162) Centromere protein B Ab [Units/volume] in Serum

140

667

2.12

15.40

1.3

1.2

91.9

43.4

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.81

15.39

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

1.1

2.4

mg/l

0.43

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

1.2

1.7

mg/l

0.19

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

0.8

2.4

mg/l

0.89

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

2.8

3.4

mg/l

0.13

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

2.7

4.1

mg/l

0.35

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

2.4

3.2

mg/l

0.25

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

0.9

1.2

mg/l

0.21

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

6.99

15.24

1.7

1.5

0.6

1.0

mg/l

0.31

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1098

8608

1.32

15.23

1.6

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

321

2.64

15.22

1.5

1.6

5.3

6.5

u/l

1.00

274

(3024522) Salmonella sp identified in Specimen by Organism specific culture

161

812

2.00

15.20

1.7

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

261

1534

1.73

15.18

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

238

2.92

15.16

2.8

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

238

2.92

15.16

2.8

2.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

357

2279

1.60

15.07

4.3

3.9

1.4

mmol/l

0.00

350

2238

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

204

1117

1.85

15.07

1.3

1.2

61.4

44.2

u/ml

0.57

129

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

239

2.90

15.05

2.8

2.0

—

(21494434) Karyotype in Bone marrow

121

550

2.22

14.98

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

129

602

2.16

14.97

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

219

2.99

14.90

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

148

732

2.04

14.76

1.9

1.6

57.7

60.9

0.42

103

455

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

242

1406

1.75

14.68

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

313

1953

1.63

14.53

4.6

4.1

3.9

mmol/l

0.69

290

1818

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.59

14.45

1.7

1.5

1.3

1.5

mg/l

0.08

(3009214) Lutropin [Units/volume] in Serum or Plasma

213

1202

1.79

14.29

1.7

1.4

10.7

11.4

u/l

0.30

179

982

(40757373) Influenza virus identified in Isolate

115

3.75

14.19

2.0

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

111

3.80

14.09

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

886

6808

1.34

14.04

3.8

3.9

11.2

22.5

ug/l

2.00

727

5550

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.42

13.96

1.3

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

185

1007

1.86

13.96

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

318

2.56

13.94

1.4

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5956

56627

1.27

13.84

5.0

4.4

1.5

mmol/l

4.65

5403

51421

(3013727) Leukocytes other/100 leukocytes in Blood

207

2.96

13.83

6.4

3.3

47.0

54.1

1.62

198

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

229

2.85

13.79

2.7

1.8

51.8

58.5

ug/l

0.41

222

(3009871) Measles virus Ab [Titer] in Serum

144

3.35

13.36

1.5

1.7

—

(3002256) Pathology report gross observation

999

7881

1.31

13.12

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

108

3.72

13.04

1.8

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

273

1697

1.63

12.90

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

500

3543

1.44

12.88

3.3

3.2

4.3

4.4

pmol/l

4.31

443

3109

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

423

2.29

12.87

1.4

1.3

562.0

362.2

titre

—

(3024928) Oxygen saturation in Venous blood

216

1264

1.73

12.82

4.0

3.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

157

836

1.90

12.72

2.7

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

274

1717

1.62

12.54

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

275

1725

1.62

12.53

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.84

12.35

2.9

2.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

143

3.23

12.13

2.2

2.0

7.8

9.6

mg/l

1.35

119

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

147

780

1.90

12.06

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.26

11.99

1.3

1.0

—

(3044941) Cell count panel - Synovial fluid

170

948

1.81

11.93

1.6

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

525

3805

1.41

11.93

1.9

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

368

2.32

11.90

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

130

666

1.97

11.84

1.2

60.6

59.0

u/l

0.09

441

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

396

2.26

11.70

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

396

2.26

11.70

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

397

2.26

11.63

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

189

1096

1.74

11.62

4.9

2.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

5535

52487

1.22

11.58

26.5

16.4

38.2

39.1

9.41

3607

35388

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

144

772

1.88

11.47

1.1

1.8

12.4

au/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

952

7609

1.29

11.23

4.7

4.6

32.7

33.1

0.47

646

4996

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

177

2.89

11.19

1.1

1.2

12.6

34.6

1.23

(40765096) Chromosome analysis panel by Banding

172

2.92

11.14

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

150

823

1.84

11.12

2.2

2.1

24.9

26.9

mg/l

0.16

202

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

394

2.22

10.99

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

260

2.51

10.85

11.5

4.8

100.8

96.7

u/ml

0.02

(1761482) Bacteria [#/volume] in Urine by Culture

269

1744

1.56

10.71

5.7

4.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

155

871

1.80

10.65

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

445

2.13

10.65

1.3

1.2

306.7

163.0

titre

0.67

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

445

2.13

10.65

1.3

1.2

145.0

106.0

titre

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

394

2.20

10.58

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

394

2.20

10.58

1.3

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

350

2.27

10.54

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

474

2.08

10.50

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

326

2.31

10.46

1.2

1.1

22.0

30.1

u/l

0.59

242

(3003434) Protein [Mass/volume] in Pleural fluid

160

915

1.77

10.38

1.6

1.5

30.7

31.4

g/l

0.26

143

818

(3052592) Norovirus Ag [Presence] in Stool

127

3.16

10.25

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

117

3.26

10.23

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1805

15627

1.20

10.18

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

193

2.71

10.11

1.5

1.2

0.6

0.3

g/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

266

1745

1.54

10.08

1.8

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

378

2.18

9.96

1.5

1.1

46.6

42.1

mg/l

0.45

315

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

327

2.28

9.95

1.2

1.1

87.2

89.1

u/l

0.06

247

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.66

9.95

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

241

1553

1.57

9.89

1.3

1.2

396.0

978.8

titre

—

(3000330) Specific gravity of Urine by Test strip

457

3342

1.39

9.87

5.1

3.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

131

717

1.84

9.84

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

367

2.19

9.84

1.3

1.1

312.0

272.3

mg/l

0.80

319

(3051651) Icteric interference index of Serum or Plasma

367

2.19

9.84

5.4

3.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

261

2.43

9.80

1.2

1.3

—

(3045414) Leukocytes [Presence] in Urine

391

2787

1.43

9.79

2.1

1.9

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

274

2.38

9.74

1.3

73.0

57.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

5.29

9.62

4.2

3.1

26.2

47.9

g/mol

0.62

(3023183) Ammonium ion [Moles/volume] in Plasma

196

1215

1.63

9.47

3.2

2.6

32.8

34.1

umol/l

0.30

166

1016

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

137

771

1.79

9.42

1.3

1.2

4.5

4.1

u/ml

0.10

328

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

335

2.22

9.42

1.3

—

(40763590) HLA-DQ beta [Type]

7.01

9.28

1.0

—

(40760410) HLA-B [Type] by High resolution

7.01

9.28

1.0

—

(46236302) HLA-C [Type] by High resolution typing

7.01

9.28

1.0

—

(40760409) HLA-A [Type] by High resolution

7.01

9.28

1.0

—

(3048879) Bone marrow aspiration report

192

2.61

9.13

1.7

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

3.03

9.09

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

277

2.32

9.07

1.3

1.1

u/l

0.07

136

(3012441) Differential panel - Pleural fluid

125

693

1.82

9.05

1.6

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

113

607

1.87

9.04

4.0

3.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

131

737

1.79

9.04

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

205

2.55

9.01

1.1

239.0

457.8

ng/l

0.58

(3023199) Leukocytes [#/volume] in Pleural fluid

139

797

1.76

8.99

1.6

1.5

4879.3

2043.6

e6/l

0.51

582

(40761536) Microorganisms panel - Urine sediment

658

5159

1.30

8.94

5.8

4.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

166

1003

1.67

8.89

1.3

64.4

43.4

u/l

0.72

140

871

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

303

2098

1.46

8.89

1.6

—

(3013862) HLA-DP [Type]

6.68

8.89

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

231

1514

1.54

8.83

3.3

3.2

0.8

nmol/l

0.31

175

1148

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

338

2.17

8.82

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

108

578

1.88

8.76

1.5

1.4

131468.5

115351.8

e6/l

0.09

387

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.55

8.65

1.9

1.2

87.6

75.6

ng/l

0.10

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.24

8.64

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

343

2444

1.42

8.64

2.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

462

1.98

8.63

1.3

10.1

12.4

u/l

1.15

421

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

402

2.05

8.56

1.6

1.5

10.2

6.0

u/l

0.46

181

(3007566) Smooth muscle Ab [Titer] in Serum

233

1543

1.53

8.51

1.3

1.2

94.2

142.8

titre

0.56

128

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.67

8.43

15.5

12.2

5.9

5.6

mmol/l

0.10

(3022493) Free Hemoglobin [Mass/volume] in Plasma

255

2.32

8.42

7.1

4.1

71.1

65.3

mg/l

0.26

177

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2018

17892

1.18

8.39

5.0

5.2

2.4

3.8

ug/l

3.87

1798

15920

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

111

611

1.83

8.26

1.3

281.5

314.9

u/l

0.44

106

580

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.82

8.22

1.2

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

276

3923

0.69

8.18

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.21

8.18

2.6

3.3

2.3

1.1

mg/l

0.44

(3051611) Lipemic interference index of Serum or Plasma

118

664

1.79

8.18

4.8

3.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

316

2.16

8.17

5.0

3.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.91

8.13

1.3

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

135

792

1.72

8.10

1.2

3.2

3.6

u/ml

0.11

262

(3045424) Erythrocytes [Presence] in Urine

166

1029

1.63

8.08

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

718

1.74

7.81

1.6

1.4

21713.3

63417.6

e6/l

2.40

425

(3047181) Lactate [Moles/volume] in Blood

286

2010

1.44

7.80

7.2

6.0

1.3

mmol/l

0.39

258

1778

(21494755) Public health laboratory ask at order entry panel

271

3813

0.70

7.60

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.80

7.51

2.1

2.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

101

558

1.82

7.47

1.7

1.5

31.9

29.7

0.25

344

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.66

7.44

1.3

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

140

853

1.65

7.34

1.6

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

272

2.18

7.28

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

149

2.63

7.27

2.1

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

359

2660

1.37

7.23

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

502

3911

1.30

7.18

2.2

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

340

2.04

7.18

1.8

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

340

2.04

7.18

1.7

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.88

7.14

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.55

7.13

1.3

1.0

—

(3012565) Volume of 24 hour Urine

288

2.13

7.10

2.2

2.4

1843.8

1892.6

0.13

254

(3024316) Viscosity of Plasma

5.19

6.96

3.1

1.6

1.9

1.7

mpas

—

(3030313) Adrenal Ab [Titer] in Serum

5.19

6.96

1.1

—

(3000012) Reticulocyte production index

365

1.98

6.94

1.7

1.4

—

(4027681)

285

2.11

6.89

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

544

1.79

6.87

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

550

4372

1.28

6.74

2.3

2.0

—

(40768806) Pleura Pathology biopsy report

119

712

1.68

6.72

1.7

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

2.89

6.72

1.7

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

6.70

1.2

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

122

736

1.67

6.68

5.3

16.2

7.2

7.3

mmol/l

0.17

101

611

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

311

2283

1.38

6.66

3.5

3.2

90.2

2951.8

u/ml

1.56

270

1937

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

173

2578

0.66

6.63

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

366

1.95

6.55

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.15

6.54

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

215

1485

1.46

6.49

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma

293

2.06

6.43

1.7

2.1

7.8

9.4

mmol/l

3.00

229

(3022621) pH of Urine by Test strip

525

4175

1.28

6.42

3.7

3.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

212

1465

1.46

6.39

1.7

1.6

365.1

309.0

mu/l

0.88

195

1327

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

928

7856

1.21

6.39

10.1

7.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

206

1417

1.47

6.36

2.5

2.2

5160.5

4881.2

u/l

0.05

565

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

172

2.39

6.34

1.1

1.2

—

(3011648) Oxygen content in Venous blood

463

1.82

6.33

3.5

2.7

10.0

10.8

1.07

463

(36660697) Celiac disease serology panel - Serum

556

4463

1.27

6.31

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

165

1087

1.53

6.29

1.8

0.9

0.8

nmol/l

1.06

124

909

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

472

1.81

6.26

1.7

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

161

2.43

6.25

1.1

1.2

90.3

86.9

0.20

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

149

2.49

6.25

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

162

2.41

6.17

1.1

88.3

87.0

0.10

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

210

1460

1.45

6.15

2.8

2.3

115.2

89.8

ug/min

0.50

135

844

(3014271) Vancomycin [Susceptibility]

390

1.88

6.08

3.7

3.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

338

1.93

5.89

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

116

716

1.63

5.87

1.4

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

339

1.93

5.84

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

2.72

5.84

1.3

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

198

2.23

5.83

1.3

3.0

3.2

mmol/l

0.21

175

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

483

1.77

5.83

1.7

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

118

733

1.62

5.82

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

189

1305

1.46

5.77

1.3

188.5

225.3

miu/ml

0.60

596

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.07

5.75

1.2

58.3

46.4

0.55

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.15

5.73

1.5

1.4

—

(3008898) HLA-B27 [Presence]

228

1632

1.41

5.72

1.1

—

(4306422)

120

754

1.60

5.66

1.2

—

(40768441) Liver Pathology biopsy report

407

1.83

5.66

1.9

1.2

—

(4010399)

526

4251

1.26

5.65

1.6

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

109

2.67

5.64

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.03

5.63

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.03

5.63

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.03

5.63

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

431

1.79

5.57

2.5

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.28

5.57

1.4

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.99

5.51

2.0

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.49

5.50

2.2

3.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

217

2.13

5.45

2.7

2.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

443

1.77

5.39

1.2

5.6

3.4

u/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.12

5.35

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

109

680

1.61

5.32

1.3

1.2

—

(3019174) dRVVT (LA screen)

3.55

5.31

1.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

380

1.82

5.28

1.3

1.5

14.9

12.7

umol/l

1.28

359

(3045788) Cell count panel - Pleural fluid

101

620

1.64

5.27

1.7

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

5.01

5.25

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.01

5.25

1.3

1.2

—

(3039000) Anion gap in Blood

203

1449

1.41

5.21

8.4

6.8

10.9

11.3

mmol/l

1.28

186

1300

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

437

3490

1.27

5.21

2.7

2.4

—

(3018572) Chloride [Moles/volume] in Blood

203

1450

1.41

5.20

8.4

6.8

104.4

105.0

mmol/l

1.09

186

1301

(3019420) Tryptase [Mass/volume] in Serum or Plasma

270

1.97

5.14

2.0

1.5

10.9

8.3

ug/l

0.31

236

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1710

15453

1.14

5.08

1.7

1.6

1.4

1.3

mmol/l

1.67

1437

12852

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1590

14300

1.14

5.08

4.3

4.5

22.9

22.0

1.41

776

7326

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.27

5.03

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.17

5.03

1.2

1.1

—

(4268621)

528

1.67

5.03

2.2

2.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

141

2.35

4.97

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

141

2.35

4.97

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

141

2.35

4.97

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

141

2.35

4.97

1.1

—

(40758292) HTLV I+II Ab panel - Serum

2.81

4.97

1.2

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

434

1.74

4.90

1.4

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

125

2.41

4.79

1.3

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

378

1.78

4.78

1.2

92.2

88.0

u/l

0.13

327

(3013762) Body weight Measured

5.01

4.77

1.0

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

196

2.10

4.75

1.2

41.9

39.5

g/l

0.46

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

100

630

1.60

4.74

1.3

—

37.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

117

765

1.54

4.72

2.7

2.4

25.6

847.6

u/ml

1.29

112

735

(3034274) Bile acid [Moles/volume] in Serum --fasting

515

1.66

4.71

1.9

10.9

8.5

umol/l

0.35

364

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

272

1.92

4.71

1.1

—

(3008295) Osmolality of Serum or Plasma

101

639

1.59

4.70

1.3

1.4

274.7

277.5

mosm/kgh2o

0.56

477

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

470

1.69

4.69

1.2

45.0

70.6

u/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

3.11

4.63

1.5

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

146

2.27

4.62

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.49

4.60

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

473

1.68

4.59

1.2

23.4

43.0

u/ml

—

(4034850)

256

1940

1.33

4.58

10.9

10.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

117

772

1.52

4.55

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

112

732

1.54

4.54

1.2

1.1

115.7

117.3

0.19

101

648

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.83

4.53

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.83

4.53

1.0

—

(3016750) Collection duration of Urine

343

1.78

4.43

2.7

2.1

502.8

489.9

min

0.53

244

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

366

1.76

4.39

1.3

0.4

1.2

u/ml

1.12

171

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

189

2.07

4.38

1.1

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

176

2.11

4.36

1.7

1.2

0.3

g/l

0.07

138

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

332

1.78

4.29

1.0

1.1

11.7

10.5

iu/ml

0.08

(40761539) Cells [Type] in Urine sediment by Light microscopy

158

2.16

4.26

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

165

2.13

4.23

1.7

1.2

105.9

112.2

0.54

143

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

199

2.02

4.21

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.74

4.17

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.66

4.14

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

123

840

1.47

4.09

1.3

0.2

0.3

nmol/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.35

4.08

1.3

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

2.33

4.07

1.5

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

200

1491

1.35

4.04

1.1

5.0

7.5

u/ml

0.48

151

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

111

2.35

3.98

1.3

1.5

127.5

137.2

ng/l

0.14

111

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

469

1.63

3.98

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.02

3.96

1.6

57.7

42.8

umol/l

1.10

(3034891) Synovial lining cells/100 cells in Synovial fluid

282

1.81

3.95

1.8

1.5

2.7

3.7

—

(3014051) Protein [Presence] in Urine by Test strip

197

1477

1.34

3.85

2.7

2.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

122

845

1.45

3.80

1.3

—

(3009992) Blasts/100 cells in Bone marrow

12.01

3.76

2.3

1.6

3.0

6.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

314

2520

1.26

3.69

1.1

342.0

174.0

titre

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.79

3.68

1.0

—

(3003338) MCHC [Mass/volume]

5015

48571

1.10

3.62

33.2

19.8

330.9

331.7

g/l

7.71

4976

48102

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

108

739

1.47

3.60

1.3

—

nmol/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

514

1.56

3.59

1.6

1.7

—

(3003129) Base excess in Capillary blood by calculation

163

2.03

3.58

2.0

1.8

-0.3

0.9

mmol/l

1.09

150

(3017446) Testosterone [Moles/volume] in Serum or Plasma

426

3546

1.21

3.57

2.5

2.1

12.0

12.1

nmol/l

0.06

360

3076

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

421

1.62

3.56

4.0

3.3

230.6

140.8

nmol/l

0.58

416

(3011985) Renin [Units/volume] in Plasma

114

791

1.45

3.55

1.9

1.4

68.0

58.4

mu/l

0.19

107

698

(3036603) Volume of Urine

399

1.63

3.52

2.3

1.7

1603.9

1870.1

0.63

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

178

1.97

3.52

1.7

1.5

0.3

0.4

ug/l

0.35

102

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.81

3.51

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

6.16

3.50

1.3

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

295

1.73

3.45

1.2

—

(3004775) Volume in Urine collected for unspecified duration

481

1.56

3.41

2.6

2.2

790.3

626.6

2.09

306

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

110

766

1.44

3.38

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.10

3.36

1.2

1.5

0.8

ml/s/173m2

1.33

(3027923) C peptide [Moles/volume] in Serum or Plasma

320

1.69

3.36

1.4

1.3

1.2

nmol/l

0.19

244

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.71

3.35

1.3

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

366

1.64

3.35

1.3

1.2

33.4

25.7

u/l

0.40

309

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.44

3.33

1.0

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.23

3.31

1.1

87.6

80.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.92

3.29

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

255

1.77

3.28

1.4

1.5

63.9

66.9

0.21

207

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

183

1.92

3.27

1.3

45.1

436.8

ug/l

1.24

(3009466) Valproate [Moles/volume] in Serum or Plasma

111

780

1.43

3.26

4.3

4.9

346.2

355.3

umol/l

0.29

666

(3004451) EKG impression Narrative

323

1.68

3.25

1.5

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.03

3.24

4.1

2.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

294

1.71

3.21

1.4

—

(3017569) Oxygen content in Arterial blood

317

1.68

3.20

2.0

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

272

1.73

3.19

1.2

141.4

134.1

nmol/l

0.35

272

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.73

3.15

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

737

1.43

3.12

1.3

295.9

315.0

pmol/l

0.15

566

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.50

3.11

5.1

5.6

404.8

380.6

umol/l

—

(3034426) Prothrombin time (PT)

180

1.89

3.08

1.1

1.2

—

(4015189)

174

1.90

3.03

2.5

2.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.84

3.02

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

190

1.85

2.96

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

588

1.47

2.95

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

155

1.94

2.93

1.5

1.6

11.8

8.9

ug/l

1.32

155

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

589

1.47

2.93

1.5

1.4

0.3

nmol/l

0.50

452

(3023323) Follitropin [Units/volume] in Serum or Plasma

230

1835

1.26

2.92

1.7

1.3

28.5

30.3

iu/l

0.35

201

1563

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.83

2.91

1.1

—

(3016038) Potassium [Moles/volume] in Urine

428

1.55

2.91

1.2

1.1

33.1

34.6

mmol/l

0.19

356

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.13

2.89

1.1

77.4

78.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

665

1.43

2.89

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

156

1.93

2.88

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.59

2.87

2.2

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

164

1.89

2.84

1.4

1.3

28.9

22.8

0.54

136

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.29

2.83

2.7

1.9

19.1

18.0

umol/l

0.15

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

182

1417

1.29

2.82

1.9

1.8

5.1

4.6

iu/l

0.20

480

(3019977) pH of Arterial blood

369

1.58

2.79

2.7

2.6

7.4

0.40

124

(3025549) Creatine [Moles/time] in 24 hour Urine

2.64

2.79

1.7

1.2

—

(3035880) pH of Pleural fluid

371

1.57

2.73

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

623

1.43

2.73

1.6

1.4

28.8

30.1

u/l

0.12

510

(3003740) Influenza virus B Ag [Presence] in Specimen

665

1.42

2.72

1.2

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.36

2.72

1.2

5.7

5.8

mmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

125

932

1.35

2.65

2.1

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

133

1.96

2.64

1.1

0.5

0.7

umol/24h

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

455

3925

1.17

2.63

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.67

2.59

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.50

2.52

8.7

5.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.03

2.52

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

111

820

1.36

2.52

1.1

200.4

745.0

iu/ml

0.37

184

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.82

2.47

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

203

1.73

2.43

1.3

1.5

16.2

15.8

pmol/l

0.16

164

(3042517) Benzodiazepines panel - Urine

2.94

2.41

2.0

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

138

1.89

2.40

1.9

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

590

1.41

2.39

3.9

3.0

64.4

42.1

mg/l

0.38

438

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1109

10189

1.10

2.38

3.2

0.8

ug/l

0.28

780

7100

(3028714) Urate [Moles/time] in 24 hour Urine

6.25

2.37

1.2

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

651

5810

1.13

2.35

1.9

1.7

1.5

0.60

549

5046

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

2.35

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

104

2.02

2.35

3.4

3.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.15

2.34

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.09

2.32

1.3

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

363

3112

1.17

2.30

3.6

3.8

36.0

71.5

u/ml

5.13

355

2991

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

162

1.79

2.30

1.7

1.3

35.9

29.8

0.32

106

(3044242) Glucose [Moles/volume] in Arterial blood

340

1.53

2.28

1.8

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.69

2.27

1.3

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

373

1.51

2.26

1.4

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

412

3578

1.16

2.23

1.2

123.3

138.2

iu/ml

0.37

142

1307

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

237

1966

1.21

2.19

2.3

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.24

2.17

1.7

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

123

947

1.30

2.16

1.6

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.29

2.15

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

186

2279

0.81

2.13

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

741

1.34

2.12

1.1

1.5

g/l

0.01

660

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

307

1.53

2.10

1.1

1.2

1.1

ratio

0.68

103

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.20

2.09

2.3

2.2

3.6

3.2

mg/l

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.00

2.07

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

214

1.64

2.05

1.5

4.4

2.5

0.59

176

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

1.80

2.04

1.1

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

2.18

2.04

13.1

1.7

7.1

8.0

mmol/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

238

1.60

2.03

1.9

2.2

183.1

132.7

umol/l

0.17

131

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.63

2.00

1.3

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.22

2.00

1.0

1.1

—

(3000492) Spirometry study

574

5142

1.13

1.99

1.7

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.55

1.94

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

289

1.53

1.94

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.19

1.94

1.5

1.3

—

(44813793)

346

1.48

1.93

1.1

—

(3024263) Appearance of Synovial fluid

322

1.49

1.92

2.5

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

157

1.72

1.92

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

165

1.70

1.90

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.86

1.86

1.1

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.86

1.86

1.3

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

129

1.79

1.85

3.0

2.8

109.1

155.7

ng/l

0.50

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.39

1.85

1.1

1.2

7.0

17.2

u/l

0.98

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

921

8497

1.10

1.84

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.27

1.80

1.1

1.2

1.5

0.8

u/ml

—

(40762365) Oxygen content in Arterial blood by calculation

101

1.88

1.80

1.9

2.9

15.3

14.7

ml/dl

0.49

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

693

1.32

1.78

1.1

3.6

3.0

u/ml

0.19

280

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

3.33

1.74

1.0

0.3

0.6

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.33

1.74

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

447

1.39

1.73

1.7

1.4

2.3

4.2

ug/l

2.17

379

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.92

1.72

2.6

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.85

1.71

1.2

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.85

1.71

5.2

5.5

—

(40768800) Prostate Pathology biopsy report

1164

0.77

1.70

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

179

1.62

1.69

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

450

4021

1.13

1.67

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.58

1.65

1.1

1.5

317.1

330.8

umol/24h

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

119

1.77

1.65

5.7

3.6

22.3

41.4

u/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

284

2462

1.16

1.65

2.4

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

228

1.54

1.64

1.4

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

253

1.50

1.62

1.5

1.7

7.5

6.4

nmol/l

0.08

209

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.84

1.61

1.4

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.14

1.61

2.8

2.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.69

1.58

1.3

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.03

1.53

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.43

1.47

1.8

2.6

—

(3025315) Body weight

2.43

1.47

5.1

4.1

—

(3000285) Sodium [Moles/volume] in Blood

1.81

1.47

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.37

1.45

1.1

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.37

1.45

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

567

1.31

1.45

1.6

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.13

1.44

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

194

1654

1.18

1.43

1.7

1.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.31

1.42

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

1.52

1.42

3.3

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

1.52

1.42

3.4

2.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.82

1.41

1.6

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

213

0.52

1.41

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

321

1.40

1.39

2.2

2.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.89

1.38

11.5

11.4

—

(3014891) Appearance of Pleural fluid

1.77

1.38

2.1

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

157

1319

1.19

1.38

2.7

3.1

232.0

720.4

u/ml

1.07

139

1195

(3025130) Human papilloma virus identified in Specimen

634

1.28

1.37

2.2

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

198

1.52

1.37

3.2

2.7

27.6

28.9

umol/l

0.20

143

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.61

1.36

9.5

7.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

223

1.48

1.35

1.0

100.3

92.0

0.63

166

(40762814) Titanium [Mass/volume] in Blood

112

1.70

1.35

2.1

2.2

4.3

3.8

ug/l

0.12

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

120

1.67

1.33

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

242

1.45

1.29

2.5

2.2

68.4

54.7

umol/l

1.04

193

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.08

1.27

1.3

1.1

—

(4212803)

1.94

1.27

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

370

1.35

1.27

2.3

1.4

0.9

g/l

0.39

370

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

518

1.30

1.26

4.5

4.7

178.3

87.1

u/ml

0.25

146

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

2.40

1.24

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

1.23

1.8

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.00

1.23

1.0

1.1

—

2.9

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.63

1.21

3.4

4.4

5.0

3.3

mg/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

164

1.53

1.20

1.8

1.7

—

(3020650) Glucose [Presence] in Urine

145

0.48

1.19

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

281

1.39

1.18

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

125

1.60

1.17

1.4

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

151

1.52

1.11

1.3

161.3

123.2

nmol/l

0.68

104

(3028707) Methadone [Presence] in Urine by Screen method

636

1.24

1.11

2.5

2.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

647

6030

1.08

1.10

1.6

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

112

937

1.20

1.09

1.8

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

294

1.36

1.09

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.95

1.08

1.1

1.2

—

(4146454)

684

1.23

1.07

2.8

2.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.65

1.06

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

129

1509

0.85

1.04

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.27

1.03

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

139

1.51

0.99

6.5

7.7

—

(37021550) Renin [Units/volume] in Plasma --upright

131

1.53

0.99

1.1

1.3

45.6

69.7

mu/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

214

1.40

0.99

3.7

2.1

559.8

4417.0

e6/l

0.54

148

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.84

0.98

1.2

1.6

3.9

4.6

nmol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

694

0.79

0.97

1.3

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

190

1.42

0.96

3.4

1.9

5233.2

23839.8

e6/l

1.02

105

(40768793) Breast Pathology biopsy report

162

1416

1.15

0.96

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

247

0.65

0.95

1.0

1.1

1.0

0.9

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

692

0.79

0.95

1.3

1.4

—

(3044007) Cell count panel - Peritoneal fluid

174

1.44

0.94

3.0

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

724

1.20

0.93

1.4

1.3

—

(3022229) Phosphate [Moles/volume] in Urine

2.22

0.93

2.3

1.7

26.2

15.7

mmol/l

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

134

1.49

0.91

5.0

2.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

322

1.31

0.90

2.5

1.8

1.3

2.8

u/field

1.23

222

(3011288) Drugs identified in Urine by Screen method

113

966

1.17

0.90

4.5

3.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.79

0.87

1.2

—

(3022689) Creatine [Moles/volume] in Urine

161

1.43

0.86

1.7

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

715

0.81

0.86

1.4

1.5

—

(3002619) Bacteria identified in Specimen by Culture

120

1.50

0.85

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

318

1.29

0.83

2.2

2.1

27.1

194.9

ug/min

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

238

0.67

0.83

1.0

5.6

0.4

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.74

0.82

2.3

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.74

0.82

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

296

0.71

0.82

1.2

1.3

—

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

122

1.48

0.80

1.4

1.2

—

(3001729) Color of Synovial fluid

1.73

0.79

1.3

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

846

0.84

0.77

1.4

—

(44806420)

208

1.35

0.77

2.3

2.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

845

0.84

0.76

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

660

1.18

0.74

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.08

0.74

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

541

1.20

0.74

2.9

2.1

1.7

2.1

u/field

0.32

198

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

842

0.84

0.74

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

360

1.25

0.74

5.9

6.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

125

1.44

0.72

1.1

1.2

18.4

16.9

umol/l

0.80

111

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

845

0.85

0.68

1.3

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

153

1375

1.12

0.65

4.2

3.6

26.1

27.7

mg/l

0.25

866

(3038071) Oxygen [Partial pressure] in Mixed venous blood

120

1.42

0.64

6.2

7.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.72

0.64

1.2

1.1

—

(4024509)

653

1.17

0.63

1.7

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

269

1.27

0.63

1.1

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

172

1.34

0.63

2.2

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

127

1133

1.12

0.62

2.3

2.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.54

0.59

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

209

0.72

0.59

1.0

1.5

2.8

u/ml

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.67

0.56

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.58

0.54

3.8

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

779

0.87

0.51

1.4

1.6

—

(3016879) Cocaine [Presence] in Urine

145

1331

1.09

0.46

2.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

854

0.89

0.45

1.1

2.5

1.7

u/ml

0.20

322

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

652

0.87

0.44

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.61

0.43

1.4

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.61

0.43

1.8

1.4

42.6

24.7

pmol/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.56

0.42

4.0

3.1

—

(3033799) Differential panel - Peritoneal fluid

194

1.24

0.41

1.8

2.0

—

(3001556) Androgen free Index in Serum or Plasma

1.52

0.41

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.33

0.40

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

141

1.28

0.40

1.1

1.2

236.0

277.3

pmol/l

0.26

101

(3022475) Manganese [Moles/volume] in Blood

1.43

0.39

1.6

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

334

1.17

0.39

5.4

13.0

—

(3005570) Glucose [Moles/volume] in Urine

664

1.12

0.39

2.6

1.9

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.39

0.38

2.8

3.5

—

0.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.39

0.38

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

448

1.14

0.37

2.0

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

819

0.90

0.36

1.7

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

153

1427

1.07

0.36

2.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

923

0.91

0.36

1.4

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

412

1.14

0.36

1.4

1.5

1.1

promille

1.02

316

(3005011) Chlamydia sp Ab [Titer] in Serum

1.36

0.36

2.6

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

489

1.13

0.35

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

758

1.10

0.33

1.9

1.7

—

(1761868) Lipid panel - Serum or Plasma

1817

18451

0.98

0.32

3.3

3.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

0.80

0.32

1.6

1.9

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

119

1.26

0.31

1.6

1.5

18.1

7.8

—

(4211845)

326

0.86

0.31

4.3

3.6

—

(4094501)

164

1547

1.06

0.30

1.1

—

(3015183) Erythrocyte sedimentation rate

231

1.17

0.29

1.1

1.3

—

(3028300) Cannabinoids [Presence] in Urine

153

1443

1.06

0.29

2.2

2.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

206

0.82

0.29

1.5

—

(4198724)

176

1.19

0.28

2.3

2.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

301

0.86

0.27

1.5

1.4

161.2

151.0

pmol/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.25

0.25

2.2

2.5

0.7

0.6

u/field

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

282

1.14

0.25

1.5

1.6

8.6

8.0

mmol/l

0.45

173

(3041806) Other cells [#/volume] in Blood by Manual count

123

1.22

0.25

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

105

1.24

0.24

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.26

0.24

1.7

3.0

—

(3027008) Opiates [Presence] in Urine

151

1436

1.05

0.23

2.2

2.0

—

(3026470) Cobalt [Mass/volume] in Blood

427

1.10

0.23

2.0

1.9

6.6

3.9

ug/l

0.38

373

(3014133) Dog dander IgE Ab [Units/volume] in Serum

568

0.91

0.23

1.1

4.5

2.8

u/ml

0.51

210

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

332

1.11

0.23

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.28

0.23

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

181

1733

1.05

0.22

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

410

1.10

0.22

1.1

1.0

237.8

336.8

ng/l

3.23

276

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

472

0.91

0.21

1.1

1.0

0.7

0.3

u/ml

0.40

116

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

5.5

—

60.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

411

1.10

0.21

1.1

1.0

762.2

703.9

ng/l

0.37

267

(3036071) Salmonella sp Ab [Titer] in Serum

173

1.16

0.20

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.20

1.0

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

413

1.09

0.19

1.1

1.0

33.5

44.8

ng/l

1.58

274

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

446

1.08

0.16

1.3

13.0

11.8

mmol/l

0.34

107

(3025577) Chromium [Mass/volume] in Blood

417

1.08

0.16

2.2

2.0

3.1

2.4

ug/l

0.42

351

(3027944) Amphetamines [Presence] in Urine

147

1415

1.04

0.16

2.1

—

(3006462) Nitrate [Presence] in Urine

298

0.91

0.16

4.4

3.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

177

1.13

0.16

1.3

3.2

—

(3020491) Glucose [Moles/volume] in Blood

439

1.07

0.15

1.5

2.1

6.1

6.7

mmol/l

1.44

296

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

163

1684

0.97

0.14

1.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.18

0.14

6.6

7.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

242

0.91

0.13

1.1

1.0

37.1

5.0

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

172

1769

0.97

0.12

2.0

1.7

6.7

3.5

mg/l

1.37

132

1271

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

123

1.14

0.12

1.1

1.0

—

(4281824)

702

0.95

0.12

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

182

1.10

0.11

1.2

1.4

—

(3006270) Folate [Moles/volume] in Blood

604

1.04

0.10

1.4

1.2

325.7

342.9

nmol/l

0.30

485

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.09

0.09

1.0

4.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

287

2825

1.02

0.09

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

756

0.97

0.09

1.1

8.5

4.3

u/ml

1.04

373

(3008401) Mugwort IgE Ab [Units/volume] in Serum

725

0.97

0.08

1.1

4.7

1.1

u/ml

0.85

303

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.05

0.08

1.2

1.1

1.4

1.7

umol/24h

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.03

0.08

1.0

—

(1002224) Polysomnography panel

189

1854

1.02

0.08

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

379

0.95

0.08

1.3

1.2

—

(44806071)

1.09

0.08

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.84

0.07

2.3

2.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.07

0.07

1.2

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

452

1.04

0.07

1.4

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

105

1073

0.98

0.06

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

119

1.09

0.06

6.5

6.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

129

1.09

0.05

1.1

1.6

1.9

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

212

0.94

0.05

1.4

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

663

0.98

0.03

1.1

1.0

2.5

u/ml

1.60

157

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

713

0.98

0.03

1.4

1.3

7.6

7.5

mmol/l

0.09

521

(4133840)

114

1.05

0.00

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

116

1.03

0.00

1.7

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

137

1.02

0.00

1.7

2.3

7.0

7.4

mmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

523

0.99

0.00

1.1

4.0

4.1

u/ml

0.02

203

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

76.6

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.00

0.00

4.5

6.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.90

0.00

1.3

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.93

0.00

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.92

0.00

2.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

137.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

38.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.00

0.00

2.3

3.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.7

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

7.8

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_ZOSTER and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_ZOSTER	1.44 [1.31, 1.58]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.045

During the follow-up period (1.1.1998 — 31.12.2019), 7716 out of 24100 females with AB1_ZOSTER died.

Males

Parameter	HR [95% CI]	p-value
AB1_ZOSTER	1.591 [1.42, 1.78]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 4984 out of 15694 males with AB1_ZOSTER died.

Mortality risk

Mortality risk for people of age

years, who have AB1_ZOSTER.

N-year risk	Females	Males
1	0.103%	0.298%
5	0.668%	1.907%
10	1.762%	4.73%
15	3.41%	8.624%
20	6.301%	14.794%

Relationships between endpoints

↥

Index endpoint: AB1_ZOSTER – Zoster [herpes zoster]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Zoster [herpes zoster]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints